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Abstract 
Lucy Haizlip Williams:  Determining the Role of the Xist non-coding RNA in Epigenetic 
Programming of X-chromosome Inactivation                                                                       
(Under the direction of Terry Magnuson) 
 
Repression of Xist RNA expression is considered a prerequisite to reversing X-
chromosome inactivation (XCI) in the mouse inner cell mass (ICM), and reactivation of X-
linked genes is thought to follow loss of Xist RNA coating and heterochromatic markers of 
inactivation, such as methylation of histone H3. I analyzed X-chromosome activity in 
developing ICMs and show reactivation of gene expression from the inactive-X initiates in 
the presence of Xist coating and H3K27me3.  Furthermore, depletion of Xist RNA coating 
through forced upregulation of NANOG does not result in altered reactivation kinetics.  
Taken together, our observations suggest that in the ICM, X-linked gene transcription and 
Xist coating are uncoupled.  These data fundamentally alter our perception of the reactivation 
process and support the existence of a mechanism to reactivate Xp-linked genes that operates 
independent of loss of Xist RNA and H3K27me3 from the inactive-X. 
 
 
 iii 
Acknowledgements 
I would like to acknowledge Dr. Terry Magnuson for his support and guidance through the 
entirety of my thesis research. Without his confidence in my abilities and daily 
encouragement, the work presented herein would not have been possible.   I would like to 
thank Dr. Larysa Pevny and Dr. Kat Hadjantonakis whose productive collaborations were 
essential for many aspects of my thesis research.  I am also grateful to Dr. Sundeep Kalantry, 
whose rigorous interactions pushed me to be a better scientist, and Dr. Stormy Chamberlain 
who taught me, as a young scientist, to trust my research instincts.   To all members of the 
Magnuson lab, thank you for your friendships; you all made lab a fun place to work!
 iv 
 
 
Table of Contents 
List of Figures .......................................................................................................................... vi 
List of Tables .......................................................................................................................... vii 
Abbreviations......................................................................................................................... viii 
Chapter 1:  Introduction ............................................................................................................ 1 
A) The Origin of X-chromosome Inactivation ..................................................................... 1 1.  Sex Chromosome Evolution ..........................................................................................................................1 2.  Two Types of X‐chromosome Inactivation Have Evolved ...............................................................4 
B) Molecular Biology of X-chromosome Inactivation......................................................... 5 1.  Initiation of X‐chromosome Inactivation ................................................................................................6 2.  Maintenance of XCI ........................................................................................................................................10 
C) Linking X-chromosome Inactivation to Cell Potency ................................................... 12 1.  X‐chromosome Activity in Pluripotent Cells.......................................................................................12 2.  Regulated Xist expression in Pluripotent Cells ..................................................................................13 
D) X-chromosome Inactivation in the Preimplantation Female Mouse Embryo ............... 15 1.  The Xp acquires epigenetic markers of XCI during preimplantation development ..........17 2.  Segregation of Cell Lineage in the ICM of the Blastocyst...............................................................17 
Chapter 2:  Imprinted XCI occurs in all cells of female blastocysts ...................................... 20 
A) Xp silencing is established in the ICM prior to epiblast specification .......................... 21 
B) NANOG does not strictly denote X-chromosome activation ........................................ 23 
 v 
D) Materials and Methods .................................................................................................. 29 
Chapter 3:  Reactivation of Imprinted XCI in the ICM.......................................................... 34 
A) Reactivation of the Xp occurs in the presence of Xi epigenetic modifications............. 34 
B) Reactivation of Xp-linked genes occurs exclusively in the epiblast lineage ................. 41 
C) Chromosome-wide transcription occurs in the presence of Xist Coating ...................... 42 
D) H3K4me2 overlaps the Xp EED domain....................................................................... 47 
E) Conclusions ……………………………………………………………………………47 
F) Materials and Methods ................................................................................................... 50 
Chapter 4:  Extinction of Xist coating has no effect on Xp genic reactivation....................... 54 
A) Increased NANOG dosage results in loss of Xi epigenetic markers of XCI................. 55 
B) Ectopic loss of Xist coating has no effect on Xp reactivation kinetics .......................... 56 
C) Maintenance of Imprinted XCI in the blastocysts ......................................................... 60 
D) Conclusions.................................................................................................................... 60 
E) Materials and Methods................................................................................................... 63 
Chapter 5:  Discussion ............................................................................................................ 65 
A) Preliminary results, Xist coating in Initiation of Random XCI ..................................... 65 
B) Future Directions ........................................................................................................... 71 
C) Concluding Remarks...................................................................................................... 75 
C) Methods.......................................................................................................................... 78 
Bibliography ........................................................................................................................... 80 
 
 vi 
List of Figures 
 
Figure 1 The Xi repressive compartment model for XCI ......................................................... 9 
Figure 2 Lineage specification in the ICM ............................................................................. 19 
Figure 3 X-linked gene expression during preimplantation development.............................. 22 
Figure 4 Imprinted Xp silencing in the early stage blastocyst................................................ 24 
Figure 5 NANOG does not denote X-chromosome Activation.............................................. 26 
Figure 6 Mid-stage ICMs exhibit increasing Xp expression .................................................. 36 
Figure 7 X-linked gene expression assayed by allele-specific RT-PCR ................................ 39 
Figure 8 Nanog expression is associated with biallelic X-linked gene expression ................ 43 
Figure 9 Mid-stage ICMs exhibit transcription within the Xp-Xist domain........................... 44 
Figure 10 Epigenetic marks associated with transcription overlap the Xp EED domain. ...... 45 
Figure 11 Grb2 -/- ICM cells exhibit loss of Xist transcripts and EED on the Xp................... 57 
Figure 12  Loss of Xist coating does not alter reactivation kinetics ....................................... 58 
Figure 13 Grb2 -/-  ICM nuclei maintain Xp-linked gene silencing through cell divisions..... 59 
Figure 14 Characterization XCI-associated epigenetic marks in mid-stage blastocysts. ....... 61 
Figure 15 Epiblast cells exhibit Xi gene silencing in the absence of Xist coating.................. 69 
 
 
 
 vii 
List of Tables 
 
Table 1  Percentage of Monoallelic, Biallelic, and Nonscorable 
 Nuclei Measured by RNA FISH ..................................................................................... 37 
 
Table 2  Mean Percentage of Xp Expression  
 As Measured Allele-Specific RT-PCR ........................................................................... 40 
 
 viii 
Abbreviations 
 
BSA  Bovine Serum Albumin 
Cdx2   Caudal-type homeobox 2 
ChIP  Chromatin Immunoprecipitation 
ChIP-seq Chromatin Immunoprecipitation Sequencing 
CSK  Cytoskeletal Buffer 
ES cells Embryonic stem cells 
EpiSCs Epiblast stem cells 
FGF  Fibroblast growth factor 
Fgf4  Fibroblast growth factor-4 
Fgfr2  Fibroblast growth factor receptor 2 
FISH  Fluorescent in situ hybridization 
Gata6  GATA-binding factor 6 
GRO-seq Global run-on sequencing 
Grb2  Growth factor receptor-bound protein 2 
H2AK119ub1 Ubiquitination of histone H2A at lysine 119 
H3K4me2 Di-methylation of histone H3 at lysine 4 
H3K9me3 Trimethylation of histone H3 at lysine 9 
H3K27me3 Trimethylation of histone H3 at lysine 27 
H4K20me1 Monomethylation of histone H4 at lysine 20 
ICM  Inner cell mass 
MSL  Male-specific lethal complex 
MOF  Males absent on the first 
MSCI  Meiotic sex chromosome inactivation (MSCI) 
MAPK  Mitogen-activated protein kinase (MAPK) 
 ix 
Nanog  Nanog homeobox protein 
Oct4  Octamer-binding transcription factor 4 
PRC2  Polycomb Repressive Complex 2 
PRC1  Polycomb Repressive Complex 1 
PARs  Pseudoautosomal regions 
RT-PCR Reverse transcribed PCR 
RNA-seq RNA-sequencing 
Sry  Sex determining region Y 
Sox2  Sry-related HMG-box 2 
Sox3  Sry-related HMG-box 3 
SNPs  Single nucleotide polymorphisms 
TSSs  Transcription Start Sites 
TS cells Trophoblast stem cells 
XCI  X-chromosome Inactivation 
Xi  Inactive X-chromosome 
Xist  X-inactive specific transcript 
Xm  Maternal X-chromosome 
Xp  Paternal X-chromosome 
WT  Wild type 
 
 
 
 
 
Chapter 1:  Introduction 
A) The Origin of X-chromosome Inactivation 
1.  Sex Chromosome Evolution 
Humans, like other mammals, are a diocecious species.  That is, sex is determined by 
chromosome karyotype.  Mammalian females have two X-chromosomes (XX), whereas 
males have one X- and one Y-chromosome (XY).  The X- and Y-chromosomes are 
genetically distinct; however, DNA sequencing indicates that approximately 5% of their 
sequence is identical.  In humans, these identical sequences, referred to as the 
pseudoautosomal regions (PARs), are grouped at the chromosome ends and undergo 
recombination during male meiosis.  The presence of the PARs suggests that the X- and Y-
chromosomes evolved from an identical origin, likely an ancestral autosome pair (Cooke et 
al., 1985; Rappold, 1993). 
The human X-chromosome contains approximately 2,000 genes that code for proteins 
utilized in a variety of cellular processes.  Contrarily, the human Y-chromosome is 
considerably degenerate, highly-repetitive, and low in gene density; the few Y-linked genes 
that have been retained code for proteins required for male sex determination, fertility, and 
fitness in male offspring (Graves, 2010).  The retention of ‘maleness genes’ and the 
degeneration of Y-linked sequence suggest a mechanism that may explain the differentiation 
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of the sex chromosome from an identical ancestral autosome; likewise, the origins of X-
Chromosome Inactivation (XCI) can also be traced to this mechanism. 
Sequencing across mammalian species indicates that Y-linked genes arose from 
mutations in proto-X-linked genes that acquired male-specific functions.  For example, the 
master controller of male sex determination the Sex determining region Y (Sry) gene can 
trace its origin to a mutation in the proto-Sox3 gene, now X-linked.  Over time, as additional 
Y-linked genes differentiated from their proto-X-linked counterparts, it became necessary to 
fix these genes on the Y-chromosome, preventing their shuffling to the X-chromosome.  
Linking ‘maleness’ genes to the Y-linked sex determination gene Sry also had the added 
bonus of ensuring that 100% of male offspring inherited alleles that were advantageous to 
males.  In order to group Y-linked genes, recombination was progressively eliminated 
between the X- and Y-chromosomes.  Comparative genomic mapping across monotremes, 
marsupials, and eutherians, has shown that the Y-chromosome accumulated regional, block-
like inversions over evolutionary time, such that ninety-five percent of the human X- and Y-
chromosome sequence do not undergo recombination in the male germline.  This contrasts 
with larger regions of recombination found between the marsupial and monotremes X- and 
Y-chromosomes.  Between identical chromosomes, homologous recombination is 
advantageous, maintaining genome integrity by repairing harmful mutations, shuffling alleles 
to preserve well-adapted haplotypes, and replacing ill-adapted haplotypes (Muller, 1964).  
While limiting recombination between the sex chromosomes was a necessity, it resulted in 
the accumulation of destructive mutations and the decay, disappearance of Y-linked sequence 
(Rice, 1994).  The X-chromosomes, which undergo homologous recombination in the female 
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germline, have preserved nucleotide integrity and thus maintained ancestral gene content 
(Graves, 2010). 
A consequence of X- and Y-chromosome differentiation is that most genes on the X-
chromosome exist as a single copy.  Ultimately, without compensatory mechanisms, protein 
production would be halved in males.  Whereas haploinsufficiency of a single gene, 
depending on the gene, many not compromise the health of an organism, haploinsufficiency 
for most X-linked genes would disturb the balance of many gene expression networks, 
resulting in decreased fitness and mortality.  To compensate for the decay of the Y-
chromosome, the activity of X-linked genes, as compared to an autosome, is increased two-
fold (Cheng and Disteche, 2006; Lin et al., 2007; Zhang and Oliver, 2007).  An upregulation 
of X-linked genes is common to many species, but the mammalian mechanism is entirely 
unknown.  In Drosophila melanogaster, expression from the single X-chromosome in males 
is upregulated two-fold, but no upregulation occurs in females (Kelley et al., 1995).  In 
mammals and Ceanorhabditis elegans upregulation of the X-chromosome occurs in both 
sexes (Cheng and Disteche, 2006).  In mammals, data suggests that a chromatin-modifying 
complex, similar to the MSL complex in Drosophila melanogaster, may have evolved to 
target X-linked sequences in general (Rea et al., 2007).  For example, in mammalian cells 
with two active Xs—undifferentiated female embryonic stem (ES) cells—both X-
chromosomes appear to be upregulated (Lin et al., 2007). 
Increasing the number of RNA transcripts from the X-chromosomes replenishes 
protein levels in males, but it creates an excess of X-linked transcripts in females.  Placental 
mammals (marsupials and eutherians) evolved a second compensatory mechanism termed X-
chromosome inactivation (XCI) (Lyon, 1961).  In any cell that has more than one X-
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chromosome per diploid autosome set, the cell inhibits transcription from all but one X-
chromosome.  Generally, XCI is thought to occur exclusively in XX females rendering X-
linked gene dosage equivalent between males and females.  It is unknown if and how XCI 
and X-chromosome upregulation mechanisms interact to achieve overall dosage 
compensation. 
2.  Two Types of X-chromosome Inactivation Have Evolved 
XCI is a developmentally regulated process.  Female offspring inherit an active X-
chromosome from both the maternal (Xm) and paternal (Xp) germline (Kalantry et al., 2009; 
Namekawa et al., 2010; Patrat et al., 2009).  In humans, XCI is initiated at the 8-cell stage of 
preimplantation development (van den Berg et al., 2009).  The choice to inactivate the Xm or 
the Xp is independent and random in each cell of the embryo.  Once XCI is initiated, the 
inactive state of that X-chromosome is replicated through cell divisions so that XCI is fixed 
with the cell’s heredity.  Random XCI produces a mosaic of cells that express X-linked genes 
either from the Xm or the Xp (Moreira de Mello et al., 2010).  In the embryo proper, random 
XCI is conserved in eutherian mammals.  However, in all tissues of marsupials and 
extraembryonic tissues of some eutherian embryos, such as rodents and bovine, only the 
paternal X-chromosome is inactivated (Takagi, 1978; Takagi and Sasaki, 1975; West et al., 
1977; Xue et al., 2002).  This form of XCI is termed, imprinted. 
The high degree of sequence homology between marsupials and eutherians (the 
marsupial X shares homology with two-thirds of the eutherian X and corresponds to an 
ancient conserved region) and observations of imprinted XCI in some eutherian tissues 
suggest that the two types of XCI may have arisen from a common mechanism (Deakin et al., 
2009).  However, models that explain XCI in eutherians utilize whole X-chromosome based 
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mechanisms.  The mechanism of marsupial XCI is unknown, but many of the whole 
chromosome epigenetic features that are inherent to eutherian XCI are not present in 
marsupials.   Marsupial XCI is also far less complete, implicating local regulatory 
mechanisms in genic silencing, which is consistent with comparative mapping studies that 
suggest sex chromosome evolution did not occur all at once (Lahn and Page, 1999).  Given 
their similar origin, it may be that silencing mechanisms have been conserved throughout the 
evolution of XCI, but many researchers in field also argue that XCI in marsupials and 
eutherians could have evolved uniquely.  Thus, imprinted and random XCI may have 
mechanistic differences.  How the mechanisms of imprinted and random XCI resemble each 
other is currently a topic of much debate. 
B) Molecular Biology of X-chromosome Inactivation 
X-chromosomes are inherited by female offspring as transcriptionally active, undergo 
inactivation during early embryonic development, and then re-activate again in the germline.  
These faithful cycles of activation and inactivation indicate that the transcriptional status of 
the X-chromosome is regulated by epigenetic mechanisms, such that XCI requires heritable 
alterations to gene expression that are not implemented by changes to the DNA sequence.  
These mechanisms must explain how: (1) genetically identical chromosomes become stably 
differentiated from one another within the same nucleus and (2) how the inactivation state is 
faithfully maintained through cell divisions during the lifetime of the female.  Based on these 
two requirements, XCI mechanisms have been divided into phases of initiation and 
maintenance. 
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1.  Initiation of X-chromosome Inactivation 
Mechanisms to explain how cells identify one X-chromosome among all the 
chromosomes in the genome to select for silencing are beyond the scope of the current 
knowledge of epigenetics.  In addition, how embryonic cells inactivate X-chromosomes at 
random or distinguish parental origin is a poorly understood subject with much complexity.  
Parent-of-origin specific XCI is an example of genomic imprinting; other examples of 
imprinted gene expression can be found at domains of autosome-linked genes (Ferguson-
Smith and Surani, 2001).  Germline-derived epigenetic modifications are hypothesized to 
regulate parent-of-origin bias in X-chromosome activity.  Data indicate that XpO mice are 
viable, and androgenetic embryos (XpXp) undergo random XCI in the extraembryonic 
tissues.  Therefore, if an inactivating Xp imprint is deposited in the male germline, then it is 
reversible (Okamoto et al., 2000; Thornhill and Burgoyne, 1993).  These data have led some 
to hypothesize that imprinting depends on marking the Xm for transcriptional activation.  In 
support of this hypothesis, XmXm embryos do not undergo XCI (Goto and Takagi, 1998).  
De novo methylation during oocyte maturation is essential for setting maternal imprints, and 
germline specific knockouts of the de novo methyltransferases disrupt parentally biased gene 
expression within imprinted domains of autosomes (Kaneda et al., 2004).  Conversely, allelic 
expression of X-linked genes is unchanged in these mutant embryos (Chiba et al., 2008).  
The X-chromosome may therefore be regulated in a manner that is distinct from traditional 
imprinting.  Future studies may elucidate the mechanisms that determine which X-
chromosome is chosen for silencing, but currently mechanisms of both imprinted and random 
XCI are unknown. 
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Initiation of XCI is marked by widespread repression of inactive-X (Xi) genes, yet 
one locus, the X-inactive specific transcript (Xist) gene, is uniquely upregulated from the Xi 
allele (Brown et al., 1991).  The Xist gene codes for a 15kb processed but untranslated RNA 
molecule that is stabilized in the nucleus and localizes in numerous copies to the Xi; this 
localization in cis is commonly referred to as Xist coating (Figure 1A) (Brockdorff et al., 
1992; Clemson et al., 1996).  Xist coating represents the earliest known event in XCI, 
occurring coincident with gene silencing, and loss-of-function mutations demonstrate that 
Xist is absolutely required for XCI (Kay et al., 1993).  Its early localization has led to the 
prevailing opinion that Xist is the master regulator of XCI, and models have implicated Xist 
coating in regulating all molecular events in the XCI process.  The exact role of Xist is yet 
undetermined, and the molecular events that lead to initiation of X-linked gene silencing are 
still being unraveled. 
Within the nucleus, each chromosome is localized to a discrete domain, called a 
chromosome territory.  The chromosome territory of the Xi is distinct from its active 
counterpart and is organized into a nuclear domain, referred to as the Xi silent repressive 
compartment that is globally depleted for RNA polymerase II (Figure 1B and C) (Chaumeil 
et al., 2006).  Microscopically, the silent Xi compartment is coated by Xist transcripts and 
Xist coating is likely responsible for folding the chromosome into its characteristic topology 
(Splinter et al., 2011).  X-linked genes, irrespective of their future expression status, are 
initially positioned at the exterior edge of the Xi domain, which is in contact with the 
transcriptional machinery; upon silencing the genic sequences are drawn into the interior of 
the silent Xi compartment and encompassed by Xist coating.  Relocation of X-linked genes 
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into the silent compartment is thought to initiate silencing by preventing access of the 
transcriptional machinery to Xi genes (Figure 1C). 
This inside-repressed/exterior-active chromosome territory model is based primarily 
on fluorescence in situ hybridization (FISH) studies interrogating the position of a small 
number of X-linked genes in relation to the Xist domain.  The chromosome territory model 
may, therefore, be an oversimplification of Xi topology.  The model also assumes that 
transcriptional machinery cannot access the interior of the Xi territory.  Within autosomal 
chromosome territories, interior positions are correlated with gene repression but are not 
repressive for the transcriptional machinery (Morey et al., 2009; Schneider and Grosschedl, 
2007).  In fact, RNAPII and chromatin remodelers are capable of accessing genes, suggesting 
that chromosome territories may be more porous than the Xi repressive compartment model 
accounts.  Localization exterior to chromosome territories is also not sufficient to induce 
autosomal gene expression.  Currently, it is unknown if chromosome topology actively 
participates in transcriptional repression or is a reflection of transcriptional repression. 
There is data to argue against Xist RNA dependent chromosome folding as the 
mechanisms of Xi transcriptional repression.  For example, two recent reports suggest 
disconnect between the exclusion of RNA Polymerase II from within the Xi territory and Xist 
coating, indicating that (1) RNA Polymerase II can be depleted from the imprinted Xp in the 
absence of Xist transcripts and that (2) inducing Xist expression does not result in formation 
of a RNA Pol II-depleted domain (Namekawa et al., 2010; Thorogood and Brown, 2010).  
Female embryos inheriting a null mutation for Xist on the paternal (Xp) X-chromosome also 
transiently initiate silencing of many Xp-linked genes (Kalantry et al., 2009).  Together, 
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Figure 1 The Xi repressive compartment model for XCI. 
(A) X-chromosomes are labeled by DNA FISH with an X-chromosome paint (green, first 
panel).  RNA FISH detects Xist transcripts (red, middle panel) coating the Xi.  The Xi is 
densely packaged relative to the more open, diffuse Xa.  (B) A domain of H3K27me3 
immunostaining (red, second panel) marks the Xi.  Within the Xi H3K27me3 domain, 
RNA Polymerase II (green, third panel) is depleted (merge), forming what is referred to as 
the Xi silent repressive compartment. (C) (1) Prior to the onset of XCI, both X-
chromosomes are active and the chromosome territories are identical.  (2) Once an X-
chromosome is chosen for silencing, Xist transcripts coat and RNA Polymerase is 
excluded from within the Xi terrority.  This forms the silent repressive compartment 
(white).  All genes are active and are located on the exterior (green).  (3) When X-linked 
genes silencing is initiated, genes are re-positioned into the interior of the compartment 
(red), such that they no longer make contact with transcriptional machinery.  (4) Histone 
modifications and other epigenetic modifying proteins form a domain over the Xi silent 
repressive compartment (orange blocks) ‘locking’ the Xi into its silent state.   
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these data imply that Xist coating may not be the single initiator of XCI, and yet 
undiscovered initiators of Xi gene silencing may exist. Thus, initiation of the XCI process 
may be more complicated than current models predict. 
2.  Maintenance of XCI 
Once Xi gene silencing is initiated, maintenance mechanisms ensure that replicated 
copies of the Xi are inherited as inactive during rounds of cell division.  The Xi exhibits 
many features characteristic of heterochromatin: it replicates late, is localized to the nuclear 
periphery, and exhibits a deficit of chromatin modifications associated with transcription, 
such as histone H4 hyperacetylation.  Contrasting the general depletion of components 
associated with transcription, chromatin at Xi genes is enriched relative to the rest of the 
genome for chromatin modifications associated with gene repression, such as trimethylation 
of histone H3 at lysine 27 (H3K27me3), mono-ubiquitination of histone H2A at lysine 119 
(H2AK119ub1), trimethylation of histone H3 at lysine 9 (H3K9me3), and monomethylation 
of histone H4 at lysine 20 (H4K20me1) (de Napoles et al., 2004; Mermoud et al., 2002; Plath 
et al., 2004; Wang et al., 2001). The molecular basis for these chromatin modifications in 
maintaining X-linked gene silencing has yet to be determined; these modifications may 
condense the chromatin or cooperate with unknown initiating factors to block the 
transcriptional machinery.  Chromatin immunoprecipitation (ChIP) experiments have 
provided some functional insight.  For example, genome-wide H3K27me3 is largely 
restricted to repressed CpG-rich promoters, (Ku et al., 2008; Mendenhall et al., 2010) yet 
H3K27me3 is also dispersed within Xi gene bodies (Marks et al., 2009). 
Methylation of CpG islands within X-linked promoters also has a critical role in 
stabilizing random XCI, but DNA methylation does not appear to play an essential role in 
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extraembryonic tissues (Sado et al., 2000).  Recently, the cohensin-like, hinge domain 
containing protein SMCHD1 has been implicated in recruitment of DNA methyltransfersases 
to the Xi (Blewitt et al., 2008).  The chromatin remodeler ATRX and the histone variant 
macroH2A also exhibit chromosome-wide Xi enrichment (Garrick et al., 2006; Mietton et al., 
2009).  Protein complexes utilized in DNA repair, such as ATM and BRCA1, and nuclear 
architecture, such as SATB1, are also associated with the Xi (Agrelo et al., 2009; Garrick et 
al., 2006; Ouyang et al., 2005; Vincent-Salomon et al., 2007).  The involvement of 
replication and nuclear organization machinery denotes that, in addition to the preservation 
of gene expression patterns, conservation of genome stability is also essential for stable XCI. 
In contrast to the rather elusive role of Xist in initiation of XCI, Xist coating has a 
defined role in maintenance of XCI.  Localization of Xist RNA is not required for long-term 
maintenance of XCI, but coating of the Xi by Xist is necessary and sufficient to establish Xi 
heterochromatin (Wutz and Jaenisch, 2000).  H3K27me3, which is the first chromatin 
modification deposited on the Xi, is catalyzed by EZH2 of the Polycomb Repressive 
Complex 2 (PRC2) (Mak et al., 2004).  Small RNAs have been shown to be co-factors for 
recruitment of the PRC2 complex to genome-wide targets, and Xist and Hotair, a long non-
coding RNA that regulates HOX gene expression, are co-factors for PRC2 recruitment (Zhao 
et al., 2010).  Female embryos lacking either Xist RNA or PRC2 components exhibit 
complete loss of Xi epigenetic markers, including H2A119ub1, H4K20me3, and macroH2A 
suggesting that Xist is also involved in recruitment of these complexes to the Xi, either 
independently or via PRC2 (Kalantry et al., 2006). 
The Xi is remarkably stable, owing to a cascade of epigenetic events that actively 
maintain the inactive state.  No one of these factors or epigenetic modifications has been 
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shown to be individually required for the maintenance of XCI and rarely are all of these 
factors/modifications detected simultaneously on the Xi.  This implies that redundant 
mechanisms or additional not-yet described factors are required for stable Xi gene silencing.  
Many of these features are regulated during the cell cycle, but some Xi chromatin signatures 
do persist through mitosis, implying active participation in the epigenetic transmission of 
XCI (Chaumeil et al., 2002; Mak et al., 2002). 
C) Linking X-chromosome Inactivation to Cell Potency 
1.  X-chromosome Activity in Pluripotent Cells 
The potency of a cell defines the cell’s potential to differentiate into multiple cell 
types.  Totipotent cells, such as germ cells, are able give rise to all the cells of the embryo, 
including extraembryonic tissues.  Pluripotent cells are slightly more restricted having the 
ability to differentiate into the three lineages (endoderm, mesoderm, ectoderm) that develop 
the embryo but cannot differentiate into extraembryonic tissues.  XCI is required in female 
cells to equalize X-linked gene expression between the sexes.  Interestingly, female totipotent 
and pluripotent cells disobey this requirement, exhibiting two active X-chromosomes 
(Epstein, 1969; Tam et al., 1994).  An association between potency and the mechanisms that 
regulate X-linked gene activity has long been hypothesized.  In further development of this 
association, reprogramming of somatic cells results in reactivation of the somatically silent 
Xi (Takagi et al., 1983).  Reciprocally, exit from pluripotency by differentiation induces 
initiation of random XCI in ES cells. 
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2.  Regulated Xist expression in Pluripotent Cells 
The pluripotent cells of the mammalian embryo are specified in the Inner Cell Mass 
(ICM) of the developing blastocyst.  In vivo, the ICM matures into the pluripotent epiblast, 
the founder tissue of the embryo.  In vitro, ICMs can be maintained in culture to derive ES 
cells that retain pluripotency along with the unlimited capacity to self-renew in culture 
(Smith, 2001).  Octamer-binding transcription factor 4 (OCT4), SRY (Sex-determining 
region Y)-box2 (SOX2), and Nanog homeobox (NANOG) function as master regulators of a 
highly integrated protein-protein interaction landscape that is necessary to establish and 
sustain the expression of thousands of genes required for pluripotency.  Moreover, these 
transcription factors are also required for proper differentiation (Boyer et al., 2005).  
NANOG, OCT4, and SOX2 co-precipitate with chromatin from a number of repressed genes 
in ES cells, termed bivalent domains, and with the help of chromatin modifying proteins, 
such as PRC2 and PRC1, have been shown to poise cells for differentiation (Bernstein et al., 
2006). 
The active X-chromosomes in female ES cells are characterized by low-levels of Xist 
expression, and coating by Xist is blocked by strong transcriptional repression of Xist via 
reduced levels of the basal transcriptional machinery associated with the Xist promoter 
(Navarro et al., 2005).    Testing the relevance of pluripotency in regulated XCI has long 
been complicated because knockdown of factors required for pluripotency forces 
differentiation of female ES cells, triggering XCI.  Recently, Navarro and Avner 
circumvented this problem by utilizing male ES cells, which normally never undergo XCI.  
These authors first showed that Xist is a direct target of OCT4, SOX2, and NANOG in ES 
cells.  Then, utilizing NANOG-depleted male ES cells these authors implicate NANOG in 
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regulating Xist repression, as loss of NANOG resulted in rapid transcriptional upregulation of 
Xist.  In separate experiments, genetic invalidation of OCT4 resulted in drastic loss of OCT4, 
SOX2, and NANOG at Xist intron 1 that was accompanied by Xist coating of the single X-
chromosome.  Based on these data, it was concluded that the activity status of X-
chromosomes in undifferentiated female cells depends on the ability of OCT4, SOX2, and 
NANOG to regulated Xist transcription and prevent Xist coating (Navarro et al., 2008).  
Similar to other repressed targets in ES cells, the pluripotency-associated transcription factors 
may also coordinate initiation of random XCI by regulating the upregulation of Xist 
expression upon differentiation (Navarro and Avner, 2009). 
These data indicate a coupling of the pluripotency-associated transcription factors in 
at least one aspect of XCI, but the mechanism underlying Xist repression remain to be 
elucidated.  For example, additional experiments are required to determine how binding of 
these factors within the first intron of Xist influences transcription.  These results have also 
not been validated in mouse embryos.  This model also assumes that all mechanistic aspects 
of XCI depend on Xist RNA.  If in fact Xi gene silencing can occur in the absence of Xist 
coating, as data analyzing imprinted XCI suggests, then additional experiments are needed to 
understand how these Xist-independent mechanisms may be regulated by cell potency. 
In contrast to mouse ES cells X-chromosome activity in female human ES cell lines is 
dynamic.  Pluripotent human ES cells exhibit three states of XCI:  class I cells carry two 
active X-chromosomes; class II cells exhibit XCI and the Xi is coated by Xist; and, class III 
cells exhibit an Xi that is not coated by Xist (Hall et al., 2008).  These data might suggest that 
a lack of XCI is not an exclusive characteristic of pluripotency.    Conversely, class I cells 
may represent the natural condition of XCI in vivo.  Class II and class III cells may be 
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epigenetically unstable having progressed beyond naive pluripotency to a pre-differentiated 
condition.  It is thought that these cells are anomalies of sub-standard in vitro culture 
conditions (Lengner et al., 2010), but recent analysis of at least one X-linked gene, Atrx, has 
suggested that the patterns of XCI evident in human ES cells may recapitulate those of 
human ICMs (Okamoto et al., 2011).  Further analysis in human embryos will likely resolve 
some of this controversy.  Even so, the current data indicate that relative Xist expression 
levels are not correlated with levels of Oct4, Nanog, and Sox2 transcripts in early passage 
human ES cell lines.  These results were supported by simultaneous appearance of Xist 
coating and OCT4, NANOG, and SOX2 protein by immunostaining (Dvash et al., 2010).   
From these data, it may be hypothesized that factors in addition to OCT4, SOX2, and 
NANOG determine X-chromosome activity in pluripotent cells, either via Xist or by 
alternative mechanisms. 
D) X-chromosome Inactivation in the Preimplantation Female Mouse Embryo 
Preimplantation development is characterized by events that prepare the embryo for 
uterine implantation and support embryonic development.  These events occur during 
discrete phases of fertilization, cleavage, and blastocyst formation.  A variety of epigenetic 
mechanisms underlie the transformation of the embryonic genome from totipotent to the 
more committed blastocyst, and imprinted X-chromosome inactivation can be considered a 
case study of the epigenetic regulation during preimplantation development (Corry et al., 
2009). 
After fertilization the epigenetic states of the oocyte-derived maternal genome and 
sperm-derived paternal genomes must be reset.  These epigenetic events are strictly 
coordinated to allow for timely zygotic gene expression (Nothias et al., 1995).  In the newly 
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formed 1-cell zygote, both maternal and paternal genomes are highly condensed and 
transcriptionally inactive; the maternal and paternal genomes are also individually packaged 
into separate membranes forming the maternal and paternal pronuclei.  Consistent with 
transcriptional repression both maternal and paternal genomes are highly methylated prior to 
fertilization.  After fertilization, the paternal genome undergoes active DNA demethylation, 
without DNA replication, that is tightly linked to male pronucleus formation (Mayer et al., 
2000; Oswald et al., 2000).   Interestingly, there is protection against active DNA de 
methylation in the female pronucleus, as well as autosomal imprinted loci in the male 
pronucleus (Nakamura et al., 2007).  Transcriptional activity is first detected in the 1-cell 
zygote when the two genomes are still individually packaged in the pronuclei.  This first 
wave of zygotic genome activation occurs earlier and at increased levels in the male 
pronucleus.  It is possible that the differential DNA methylation and transcriptional activation 
between the maternal and paternal genomes at the 1-cell stage may drive differential 
treatment of the X-chromosomes in imprinted XCI. 
The first cleavage division is characterized by synkaryogamy, the breakdown of 
pronuclear membranes and fusion of maternal and paternal genomes.  At the 2-cell stage, 
zygotic genome activation is complete and both X-chromosomes are active in the 2-cell stage 
embryo (Kalantry et al., 2009; Namekawa et al., 2010; Patrat et al., 2009).  The Xm retains 
its activity throughout preimplantation development.  The Xp, conversely, exhibits gradual 
accumulation of epigenetic modifications associated with heterochromatin.  The 
accumulation on the Xp of repressive marks contrasts with the gradual, passive genome-wide 
DNA de methylation that is inherent to the epigenetic profile necessary for differentiation 
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into trophectoderm, primitive endoderm, and epiblast at the blastocyst stage (Morgan et al., 
2005). 
1.  The Xp acquires epigenetic markers of XCI during preimplantation development 
Initiation of imprinted XCI is first observed by the microscopically detectable 
depletion of RNA Polymerase II from the Xi territory at the 4-cell stage, which coincides 
with coating of the chromosome by Xist.  By the 8-cell stage, Xist coating is apparent on the 
Xp in all nuclei.  At this time, Xp-linked gene silencing is initiated, with some nuclei of the 
8-cell stage embryo showing silencing of Xi genes.  Xist coating recruits PRC2, and by 
blastocyst stage, there is an observable H3K27me3 enrichment domain that colocalizes with 
the Xp in all nuclei (Mak et al., 2004; Okamoto et al., 2004). 
2.  Segregation of Cell Lineage in the ICM of the Blastocyst 
The blastocyst stage of preimplantation development is not discrete; in fact, over 
approximately 36 hours of development, the mouse blastocyst undergoes dynamic 
differentiation.  The early-stage blastocyst (~32 cells) is divided into two cell populations, 
trophectoderm and ICM.  The trophectoderm is the progenitor of the placenta.  
Trophectoderm cells line the exterior of the blastocyst and become distinguished by 
expression of Cdx2 and repression of pluripotency-associated transcription factors Oct4 and 
Sox2.  The ICM reciprocally expresses Oct4 and Sox2 (Dietrich and Hiiragi, 2007).  As the 
blastocyst expands, the ICM segregates into two populations of cells, primitive endoderm 
and epiblast that exhibit expression of lineage specific transcription factors Gata6 and 
Nanog, respectively (Figure 2A).  At the mid-stage (~32 to 64 cells) of blastocyst 
development, primitive endoderm and epiblast cells are randomly distributed within the ICM; 
however, by the late (greater than 64 cells) blastocyst stage, the endodermal lineages have 
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migrated to the exterior edge of the ICM and have upregulated Gata6 (Figure 2A).  The 
epiblast cells at this stage have high levels of Nanog expression (Plusa et al., 2008).  The 
separation of primitive endoderm and epiblast cells in the ICM is thought to be directed by 
FGF signaling, and mutations in components of FGF signaling including Fgf4, Fgfr2, and 
Grb2 results in early post-implantation lethality due to lack of primitive endoderm 
development (Figure 2B) (Lanner and Rossant, 2010; Yamanaka et al., 2010). 
Given the presence of Xi epigenetic markers on the Xp in all cells, current models 
predict that all cells of the blastocyst establish imprinted XCI (Mak et al., 2004; Okamoto et 
al., 2004).   In the following chapters, we provide definitive evidence, utilizing X-linked gene 
silencing, that imprinted XCI is established in all cells of the preimplantation embryo, 
supporting the current model.  Imprinted XCI is thought to persist in the progenitor cells that 
will give rise to the extraembryonic tissues.  Based on data from ES cells showing that 
OCT4, SOX2, and NANOG can repress Xist expression, upregulation of Nanog and 
subsequent loss of Xist coating in the epiblast cells of the late-stage ICM is thought to trigger 
reactivation of the imprinted Xp (Navarro and Avner, 2009).  The result is that both X-
chromosomes are active in the epiblast, and initiate subsequent random XCI upon 
gastrulation.    Here, we examine the kinetics of reactivation in the ICM and in doing so, we 
hypothesize a new model for X-chromosome reprogramming and provide new insight into 
the mechanism of X-linked gene silencing.  
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Figure 2 Lineage specification in the ICM. 
(A) The ICM in early blastocysts consists of uncommitted cells (green) expressing 
both Gata6 and Nanog.  As the blastocyst develops, ICM cells begin to upregulated 
expression of either Nanog (blue) or Gata6 (yellow).  At late blastocyst stage, 
upregulation of Nanog and Gata6 is complete such that cell fate is determined.        
(B) In early ICMs, cells exhibit variable levels of Fgf4 and Fgfr2 expression.  The 
variability in these levels is enhanced as the ICM develops.  Cells (yellow) exposed to 
high Fgf4 upregulate Gata6, which in turn results in down-regulation of Nanog 
expression.  Where Fgf4 signaling is low (blue), Nanog expression is upregulated and 
Gata6 is eventually repressed.       
  
Chapter 2:  Imprinted XCI occurs in all cells of female blastocysts
  
Previous analyses of X-linked gene expression quantified total mRNA by reverse-
transcribed PCR (RT-PCR) in whole preimplantation embryos (Huynh and Lee, 2003; 
Okamoto et al., 2004; Ouyang et al., 2005; Singer-Sam et al., 1992).  These results indicated 
that Xp-linked genes were expressed from the 2-cell to the 8-cell stage.  At the 8-cell stage, 
the first Xp repression is detected (Kay et al., 1993).  Utilizing RNA FISH, which detects 
gene activity with single-cell resolution, these results were corroborated; however, Xp 
silencing is heterogeneous in preimplantation embryos, with many nuclei having two-active 
X-chromosomes through the blastocysts stage (Figure 3B).  One other group has 
independently reproduced these results (Patrat et al., 2009).  All of these experiments have 
been performed on whole embryos.  Here, we re-examined X-linked gene expression 
considering that the embryo contains two populations of cells: trophectoderm and ICM 
(Chazaud et al., 2006).  We were especially curious about transcriptional status of the Xp in 
the ICM, which represents a minority of total cells in the mature blastocyst (approximately 
10%).  At stages of ICM development, ICM cells express pluripotency markers Oct4, Sox2, 
and Nanog.  We reasoned that the presence of OCT4, SOX2, and NANOG prevents ICM 
cells from fully establishing imprinted XCI, contributing to the reported incomplete Xp 
silencing in whole embryos. 
 21 
A) Xp silencing is established in the ICM prior to epiblast specification 
To determine if all cells of the preimplantation stage embryo exhibit imprinted XCI, we 
analyzed transcription of X-linked genes by RNA fluorescent in-situ hybridization (RNA 
FISH).  RNA FISH detects nascent transcripts at the origin of transcription.  We analyzed 
ICMs isolated by immunosurgery (Solter and Knowles, 1975) from early-stage (~32 cell 
stage embryo) blastocysts . 
Early-stage blastocysts were chosen for analysis because cell lineage in ICMs has not 
been specified; the early-stage ICM consists of a homogenous population of uncommitted 
cells (Plusa et al., 2008).  We assayed five X-linked genes (Rnf12, Atp7a, Abcb7, Ube1x, and 
Mecp2) that are expressed at robust levels during preimplantation development (Kalantry et 
al., 2009; Patrat et al., 2009).  RNA FISH had previously been used to analyze these five X-
linked genes in whole embryos (Kalantry et al., 2009; Patrat et al., 2009).  We assayed 
expression of the five X-linked genes together with Xist RNA, which is known to coat the Xp 
in all nuclei (Mak et al., 2004).  If the Xp-allele of the five genes assayed is silenced, RNA 
FISH will yield a single monoallelic gene signal indicative of transcription from the Xm.  In 
contrast, if the Xp-linked gene is not silenced, our assay will detect gene expression from 
both X-chromosomes (biallelic), and of the two RNA FISH signals will colocalize with the 
Xist domain.  As a positive control, we measured expression of Smcx, a gene known to 
escape XCI during preimplantation development (Agulnik et al., 1994; Patrat et al., 2009).  
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Figure 3 Transcription of X-linked genes during preimplantation development. 
(A) The positions of the five X-linked genes analyzed by RNA FISH are graphically 
represented on the X-chromosome.  Mb = megabase (B) For each X-linked gene, the 
kinetics of silencing during preimplantation development is graphed as a percentage of 
biallelic nuclei per total nuclei. (C) In early ICMs, RNA FISH is capable of detecting 
biallelism and monoallelism in the same nuclei (merge), which is indicated by detection 
of Smcx (red) and Rnf12 (green) primary transcripts.  Arrowheads mark biallelic 
expression of Smcx, an X-linked gene that escapes imprinted XCI (first panel).  In 
contrast, a single arrowhead demarks monoallelic expression of Rnf12 (middle panel). 
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As expected, Smcx exhibited 97% biallelic expression in early ICMs, demonstrating that our 
assay is capable of detecting X-linked gene transcription from the Xp (Figure 3C).  In 
contrast, Rnf12, Atp7a, Abcb7, Ube1x, and Mecp2 demonstrated an average low level of 
biallelism ranging between 5% and 23% of cells per ICM (Figure 4A and B).  The degree of 
silencing depended on the gene assayed.  For example, Mecp2 had been reported to escape 
imprinted XCI, but we detected the average number of biallelic nuclei to be 18% of total 
nuclei examined (Patrat et al., 2009)  Rnf12, Atp7a, and Abcb7 exhibited efficient silencing 
with less than 10% biallelic nuclei.  For all genes analyzed, the low level of biallelism in 
early ICMs was comparable to the level of biallelism found in the trophectoderm (Figure 
4B).  For Rnf12, Atp7a, Abcb7, and Ube1x a number of individual ICMs exhibited exclusive 
monoallelic X-linked gene expression in every nucleus, arguing against the possibility that a 
subset of ICM nuclei never undergo Xp silencing.  Together, these data illustrate that the 
majority of nuclei exhibit an inactive Xp, thus the Xp undergoes imprinted XCI in the 
preimplantation embryo prior to specification of the embryonic lineage. 
B) NANOG does not strictly denote X-chromosome activation 
The finding that the Xist gene is a direct target of OCT4, SOX2, and NANOG 
suggests that these transcription factors are directly responsible for regulating X-chromosome 
activity.  It has been proposed that Xist expression and as a by-product X-chromosome 
activity, is regulated by these transcription factors (Navarro and Avner, 2009).  OCT4 and 
SOX2 are maternally supplied in the oocyte and exhibit widespread zygotic expression and 
protein localization patterns during preimplantation development.  In contrast, NANOG is 
not maternally supplied; its zygotic expression is first detected at the 8-cell stage. 
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Figure 4 Imprinted Xp silencing in the early stage blastocyst. 
(A) A representative ICM assayed for Atp7a (red, top panel) and Xist/Tsix (green, middle 
panel) by RNA FISH. The Xist probe detects Xist RNA and the anti-sense transcript Tsix.  
Xist marks the Xp as a cloud at this stage.  In ICMs, Tsix is detected in some nuclei as a 
pinpoint signal from the Xm (Lee et al., 1999). In the merge image, all nuclei exhibit 
monoallelic Atp7a expression, localized away from the Xp-Xist coat (green domains).  A 
single nucleus is highlighted in the right corner of each image.  (B) Distributions of 
monoallelic (black), biallelic (grey), and nonscorable (white) nuclei are presented as 
average percentage of total nuclei per early ICM or trophectoderm.  The distribution 
indicates that early ICMs exhibit a similar degree of monoallelic X-linked gene expression 
as the trophectoderm. 
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preponderant role in regulating Xist expression.  It was also reported that NANOG positive 
cells in the early-stage blastocyst exhibited an Xp that did not have Xist coating(Mak et al., 
2004). 
The levels of NANOG vary in individual cells of undifferentiated ES cells and ICMs 
of mature blastocysts (Plusa et al., 2008).  Given its role as a rheostat in regulating the 
achievement of ground-state pluripotency, we wondered if the levels of NANOG confer X-
chromosome activity in the preimplantation embryo (Silva et al., 2009).  Our 
immunostaining showed both strong and moderate NANOG staining in early-stage 
blastocysts.  Importantly, high levels of NANOG colocalized with CDX2 (Figure 5A).  Since 
CDX2 is a marker of extraembryonic cells, the colocalization of CDX2 and NANOG suggest 
that the presence of NANOG in early ICM nuclei is not indicative of epiblast specification, 
which is consistent with previous reports (Plusa et al., 2008).  Connecting lineage 
specification to XCI, the colocalization of these markers makes it is also unlikely that 
NANOG denotes Xist repression. 
As the blastocyst matures NANOG becomes restricted to the epiblast cells (Plusa et 
al., 2008).  We reasoned that Nanog transcription is tightly regulated during blastocyst 
development, such that in contrast to protein localization Nanog transcripts may be detected 
only in cells that will retain NANOG at later stages.  We performed RNA FISH with a probe 
that detects Nanog nascent transcripts.   We examined early ICMs to determine if the few 
cells with an active Xp were exhibiting on-going Nanog expression.  We found there was no 
association between Xp activation and Nanog expression (Figure 5B).  The combination of 
our RNA FISH and immunostaining data argue that Nanog expression and NANOG 
localization are not markers of X-chromosome activation in the early stage blastocyst.  
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Figure 5 NANOG does not denote X-chromosome Activation.   
(A) Early-stage blastocysts were immunostained for NANOG (green) and CDX2 
(red), which is a marker of trophectoderm nuclei.  Both lineage markers are 
present at high and low levels throughout the embryo, and some nuclei contain 
high levels of both NANOG and CDX2 (yellow, merge).  (B) Nanog and Atp7a 
nascent transcripts are detected by RNA FISH in early-stage ICM nuclei.  We see 
that in Nanog positive nuclei of early-stage ICM the Xp is silent, determined by 
monoallelic Atp7a expression. 
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C) Conclusions 
Based on a genome-wide analysis of chromatin architecture in ES cells, pluripotent cells are 
defined by an open chromatin landscape, devoid of compaction.  8-cell stage mouse embryos 
have chromatin distributions similar to ES cell chromatin profiles, with an extended 
meshwork of loosely packaged chromatin, consistent with the embryo’s uncommitted 
potential (Ahmed et al., 2010).  This chromatin profile would appear non-conducive to 
initiation of XCI in that the Xi is characterized by chromatin compaction. 
We utilized X-linked gene expression as the definitive marker of established XCI.  
Our data indicate that Xp-linked gene silencing is uniformly initiated in the early-stage 
blastocyst, such that ICMs and trophectoderm exhibit similar profiles of biallelic gene 
expression.  These data confirm that, in the preimplantation mouse embryo, (1) all cells 
initiate imprinted XCI, (2) extraembryonic cells maintain imprinted XCI, and (3) epiblast-
specified cells reprogram imprinted XCI, such that random XCI can be initiated at 
gastrulation. 
Our data clearly show that preimplantation mouse embryos violate the rule of X-
chromosome activation in female uncommitted cells.  Mice are the primary organisms used 
in studies of XCI, but limited data indicate that other mammals also undergo XCI during 
preimplantation development.  In bovine embryos, XCI is imprinted and the kinetics of XCI 
in bovine is very similar to mouse (De La Fuente et al., 1999).  In rabbit embryos, XCI is 
delayed relative to mouse but analysis of one X-linked gene, Hprt, suggests robust Xi 
silencing has occurred by blastocyst stage.  Significantly, the Xi is not reactivated in mature 
rabbit ICM cells, irrespective of the presence of OCT4, SOX2, and NANOG.  Conversely, 
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human preimplantation embryos do not initiate Xi gene silencing, but Xist transcripts 
associated with X-chromosomes in nuclei of mature ICMs (Okamoto et al., 2011).  XCI 
mechanisms are therefore highly diverse in early embryos and no clear association between 
cell potency and X-chromosome activity can be made. 
Why do all cells of the mouse preimplantation embryo undergo imprinted XCI?  One 
possible explanation is that XCI may be driven by the need of the preimplantation embryo to 
establish dosage compensation before trophectodermal lineage commitment.   During mouse 
development, the trophectoderm is the first lineage specified and the majority of cells in the 
blastocyst are committed to the trophectoderm lineage.  Trophectoderm specification occurs 
at compaction in the 32 cell stage mouse embryos and irreversible commitment is established 
by the mid-stage of blastocyst development (Dietrich and Hiiragi, 2007; Strumpf et al., 
2005).  Commitment of cells to trophectoderm is directed by Cdx2-dependent repression of 
Oct4 expression (Niwa et al., 2005).  Interestingly, bovine trophectoderm co-expresses Oct4 
and Cdx2 and lineage commitment is delayed relative to mouse (Cauffman et al., 2005; 
Kobolak et al., 2009).  Species-specific variability in trophectoderm commitment may be 
connected to implantation timing.  For example, uterine implantation occurs after 
gastrulation in bovine embryos; approximately two weeks post-blastocyst formation (Berg et 
al., 2010).  Mouse embryos implant and undergo extensive trophectoderm proliferation and 
differentiation, forming giant cells, ectoplacental cone, and extraembryonic ectoderm within 
24 hours of blastocyst formation. 
I show that imprinted XCI is established throughout the embryo prior to 
trophectoderm lineage commitment.  Given that the majority of cells in the blastocyst are 
specified to trophectoderm, I propose that imprinted XCI is globally established in the early 
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blastocyst in order to ensure that the Xp is silenced before the trophectoderm is committed.  
It is likely more favorable for the embryo to initiate imprinted XCI in all cells, rather than 
risk the absence of X-chromosome dosage compensation in trophectoderm.   This hypothesis 
is supported by phenotypic analysis of female embryos that have inherited mutations 
rendering imprinted XCI unstable in the trophectoderm; these embryos exhibit substantial 
loss of the trophectoderm-derived tissues, such as the extraembryonic ectoderm and the 
ectoplacental cone (Wang et al., 2001).  Thus, the absence of dosage compensation in the 
committed multipotent trophectoderm is incompatible with development.  Given that bovine 
embryos exhibit delayed trophectoderm commitment, it would be very interesting to compare 
the kinetics of Xp silencing between bovine and mouse. 
D) Materials and Methods 
Embryo collection and Immunosurgery 
Embryos were collected from natural mating of Mus. domesticus CD1 females to 
CD1 males carrying the X-GFP (D4.EGFP) transgene (Hadjantonakis et al., 1998).  CD1 
animals were obtained from Charles River Laboratory.  Female blastocysts were 
distinguished from males by GFP expression.  Mice were exposed to light daily between 
6:00AM and 6:00PM.  The morning of the day the plug was detected was considered E0.5.  
Early blastocysts were collected between E2.75 and E3.0 (approximately 66-72 hours post-
copulation).  Because embryos collected at the same time varied in developmental stage, 
blastocysts were also staged according to relative size (a qualitative measure of total cell 
number) and blastoceol cavity expansion.  Early blastocysts can be distinguished by the 
absence of or a small blastoceol cavity. 
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Immunosurgery procedures were performed as previously described (Solter and 
Knowles, 1975).   Blastocysts were flushed out of the uterus into room temperature M2 
media (Millipore, EmbroMax #MR-015-D).  Zona pellucidae were removed by washing 
blastocysts through Acidic Tyrode’s Solution (Sigma, T1788).  Embryos were allowed to 
recover for 5 minutes in room temperature M2 after zona pellucida removal.  Subsequent 
steps were performed in 20 µl drops of media covered with a layer of light mineral oil in a 
35mm tissue culture dish.  The embryo culture dish was pre-equilibrated at 37°C with 5% 
CO2.   First, embryos were incubated for 30 minutes at 37°C with 5% CO2 in whole anti-moue 
serum produced in rabbit (Sigma, M5774) diluted 1:10 with M2 media.  Second, embryos 
were washed five times with M2 media.  For each wash, embryos were allowed to sit in 20ul 
of M2 media for 5 minutes.   Finally, embryos were incubated for 30 minutes at 37°C with 
5% CO2 in guinea pig complement (isolated previously by Terry Magnuson) diluted 1:10 in 
M2 media.  After incubating in guinea pig complement, trophectoderm cells are lysed.  
Trophectoderm cells were removed by manually pipetting up and down using a finally drawn 
mouth pipette. 
RNA FISH 
 FISH probes were generated from BAC and FOSMID clones ordered through 
bacpac.chor.org.  100 ng of probe DNA was labeled using Bioprime Labeling Kit 
(Invitrogen) with FITC-dUTP (Roche), Cy3-dCTP (GE Healthcare), or Cy5-dCTP (GE 
Healthcare).  The BACs and FOSMIDs are as follows: G135P65743A11 (Ube1x); 
G135P67639H10 (Mecp2); G135P63425C4 (Xist/Tsix); G135P605237C7 (Rnf12); 
G135P62497G3 and G135P64951A11 (Atp7a); RP24_274B9 (Abcb7); G135P60362749 
(Smcx); and G135P60684137 (Nanog).  BACs and FOSMIDs were chosen so that they did 
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not over lap multiple X-linked genes.  All RNA FISH probes used to detect X-linked genes 
were tested in trophoblast (TS) cell lines to determine detection of X-linked sequences with 
expected expression patterns.  The Nanog probe was tested in ES cell lines.  300 µg of yeast 
tRNA (Invitrogen), 15 µg of mouse Cot-1 DNA (Invitrogen), 100 µl of sheared, boiled 
Salmon Sperm DNA (Invitrogen), and 10 µl of 3M NaAcetate were precipitated with 100 µl 
of labeled FISH probe in 100% ethanol by centrifuging for 30 minutes at maximum speed.  
The precipitated probe was washed once in 70% ethanol, once in 100% ethanol, and then air-
dried to remove all traces of ethanol.  The dried pellet was resuspended in 50 µl of 100% 
Formamide, denatured for 10 minutes at 80°C, and then cooled on ice.  50 µl of hybridization 
buffer (1 part RNAse free water, 1 part RNAase free 20XSSC, 1 part 10mg/ml RNAse free 
Bovine Serum Albumin, and 2 parts Dextran Sulfate) was then added.  The probe mixture 
was vortex and then pre-annealed at 37°C for 1 hour.  Finally, the probe was stored for 
repeated use at -20°C. 
 ICMs were prepared for RNA FISH by incubating in 0.05% trypsin just until the 
individual nuclei in the ICM cluster were visibly distinguishable (no fixed time was 
determined, I simply watched the ICM in trypsin).  Typically, incubation time was under 30 
seconds.   It is important not to dissociate the ICM into individual nuclei because this will 
make pipetting impossible; keep the ICM as a cluster of cells. ICMs were then washed 
through M2 plus 10% fetal calf serum in order to neutralize the trypsin.  ICMs were 
permeabilized for 15 seconds in cytoskeletal buffer (CSK), 1 minute in CSK plus 0.05% 
triton-X, and 15 seconds in CSK.   The recipe for CSK is: 100mM NaCl; 300mM Sucrose; 
3mM MgCl2; and 10mM PIPES pH6.8.  Bring CSK up to final volume with sterile RNAse 
free water and store the CSK at 4°C.  An aliquot of CSK was taken made fresh prior to each 
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experiment, RNAsin (Invitrogen, 10441020) was added, and all incubations were performed 
on a cold block.  Finally, ICMs were mounted onto coverslips that were previously coated 
with 1x Denhardt’s Solution (Sigma, 30915) in CSK plus 1% Paraformaldehye 
(paraformaldehyde was diluted in 1xPBS plus 6mg/ml BSA).  After the ICMs have laid 
down on coverslips, the CSK plus 1% paraformaldehye is gently pipetted off of the ICMs.  
Because of the trypsin treatment, this sucking action should cause the ICM clusters to flatten 
out on the coverslips.  Coverslips were then air dried for 10 minutes and stored in 70% 
ethanol at -20°C until ready to use for RNA FISH. 
 ICMs were dehydrated through an ethanol series of 80%, 90%, and 100% ethanol 
follow by then air-drying to remove the ethanol.  For each coverslip, 10 µl of precipitated 
RNA FISH probe was hybridized overnight at 37°C.  Next day, washes were performed at 
42°C:  3 washes with 50% Formamide/2XSSC, 3 washes with 2XSSC, and 2 washes with 
1XSSC.  Coverslips were mounted onto glass slides with Vectashield plus DAPI mounting 
media (Vector Labs, H-1500). 
Microscopy 
 Images for RNA FISH were obtained using a Leica DML fluorescence microscope 
with a Q-imaging Retiga 200R camera and Q-capture software. Images were processed using 
SPOT RT Software (Diagnostic Instruments).  Images for immunostaining were obtained 
using the Zeiss 710 confocal microscope and processed using the Zeiss software. 
Immunostaining 
 Immunostaining was performed in Terasaki culture dishes.  Blastocysts (with zona 
pellucida removed) were fixed in 3% paraformaldehye diluted in 1xPBS plus 6mg/ml BSA 
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for 10 minutes at 25°C.  After washing five times in 1xPBS plus BSA, blastocysts were 
permeabilized for 15 minutes in 0.5% tritonX-100 diluted in 1xPBS plus BSA then washed 
again in 1x PBS BSA.  Blocking was performed in 10% heat inactivated goat serum for 1 
hour at 25°C.  Primary antibodies were Nanog (Chemicon, 1:1000) and Cdx2 (Biogenex, 
1:200); dilutions were performed in blocking solution.  Primary antibody incubations were 
performed overnight at 4°C, followed by washing in 1x PBS plus BSA, and incubating in 
secondary antibody for 45 minutes at 25°C.  Secondary antibodies coupled to AlexaFlour 
594 (Invitrogen A-11037) and AlexaFlour 488 (Invitrogen A-11039) were diluted to 1:500 in 
10% goat serum.  The embryos were washed in 1x PBS plus 6mg/ml BSA.  In order to avoid 
smashing the blastocyst during mounting, blastocysts were mounted into 0.12 mm deep 
Secure-Seal spacer wells (Invitrogen Cat. # S24737) that were fixed onto microscope slides.  
Mounting media was a dilution of 1:1 Vectashield (Vector Labs) with DAPI in 1x PBS (no 
BSA).  Because the mounting media is not a hard set, the slides were stored flat so that the 
embryos did not move after mounting.  This mounting media was used alternative to other 
medias because the blastocysts did not collapse in the media.  Slides were imaged using an 
upright confocal microscope; this was important because the blastocysts were mounting in 
the spacer wells.  If imaging was performed on an inverted microscope, the blastocysts were 
prone to move during the imaging making it impossible to obtain Z-stacks.
Chapter 3:  Reactivation of Imprinted XCI in the ICM
 In Chapter 2, I showed that naïve epiblast cells in the ICM undergo an inactivation-
reactivation cycle to prepare for random XCI in the mature epiblast.  Detailed analysis of 
reactivation in the ICM has not yet been performed; I analyzed both the kinetics of Xp-linked 
gene reactivation and loss of Xi epigenetic modifications to gain insight into mechanisms of 
XCI. 
 Given that (1) Xi gene silencing is thought to be a consequence of Xist coating and (2) 
the Xi is enriched for epigenetic marks that are hallmarks of transcriptionally inactive 
chromatin, a prerequisite of X-linked gene reactivation is hypothesized to be the sequential 
loss of Xist coating, epigenetic modifying proteins, and chromatin modifications.  Xist 
coating and PRC2/H3K27me3 enrichment domains are lost from the Xp in the mature ICM 
of late (fully expanded) blastocysts (~128 cell stage embryo) suggesting that reactivation is 
initiated at this time (Mak et al., 2004; Okamoto et al., 2004). 
A) Reactivation of the Xp occurs in the presence of Xi epigenetic modifications 
 To investigate the kinetics of Xp reactivation, I first isolated ICMs from mid-stage 
female blastocysts (~ 32 to 64 cell stage embryo), which is a developmental time point 
reported to be prior to loss of Xi epigenetic modifications from the Xp.  I performed dual 
immunofluorescence to detect NANOG, which marks epiblast cells in the ICM, and the 
PRC2 subunit EED.  On average 90% of NANOG positive nuclei contained an EED Xp
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domain (Mak et al., 2004; Okamoto et al., 2004; Silva et al., 2009) (Figure 6A and B).  
 Xist coating and EED/PRC2 accumulation on the Xi are surrogate markers of X-linked 
gene silencing so I investigated the transcriptional status of X-linked genes directly using 
RNA FISH and allele-specific RT-PCR.  Assaying the same five X-linked genes that 
previously showed predominantly monoallelic expression in early ICMs, I detected biallelic 
expression in 35-50% of cells from mid-stage ICMs (Figure 6C), depending on the X-linked 
gene analyzed.  Importantly, in all cases of biallelism one of the two X-linked gene signals 
co-localized with Xp-Xist and H3K27me3 accumulation (Figure 6D).  For all five X-linked 
genes analyzed, I observed a statistically significant increase in the average number of 
biallelic nuclei and a corresponding decrease in monoallelic nuclei (p<0.01; Table 1). 
I presented in Chapter 2 that for each X-linked gene analyzed, an active paternal 
allele is present in a low percentage of total ICM and trophectoderm nuclei of early-stage 
blastocysts.  It may be reasonable to assume that Xp expression in the mid-stage ICM is a 
consequence of escape from Xp silencing in a subset of early-stage ICM nuclei.  Importantly, 
eleven of fifty-three early-stage ICMs exhibited 100% monoallelic nuclei.  In contrast, I 
never analyzed a mid-stage ICM that were100% monoallelic.  Cell divisions in the ICM have 
been reported to occur approximately every 11.5 hours (Bischoff et al., 2008); consequently,  
cell number can do no more than double between the early to mid-stage of ICM 
development.  For the increasing biallelism to occur due to escape from imprinted XCI, I 
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Figure 6 Mid-stage ICMs exhibit increasing Xp expression.  
(A) Mid-stage blastocyst immunostained for NANOG (green, left panel) and EED (red, 
middle panel).  The cropped nucleus (marked by an arrow) illustrates a NANOG positive 
nucleus with Xp EED domain.  (B) The distribution of NANOG positive ICM nuclei 
exhibiting an Xp EED enrichment domain is graphed.  A red bar represents the average.  N is 
the number of mid-stage blastocysts analyzed. (C) Distributions of biallelic (black), 
monoallelic (grey), and nonscorable (white) nuclei presented as an average percentage of 
nuclei per ICM.  In mid-stage ICMs there is a statistically significant (p<0.01) increase in 
biallelism. (D) A representative nucleus illustrates biallelic Abcb7 (red punctate signal) 
expression.  H3K27me3 accumulates on the Xp above genomic levels (cyan domain).  The 
H3K27me3 enrichment domain colocalizes with Xp-Xist coating (green cloud).  The merge 
image (fourth panel) indicates that one of the two Abcb7 RNA FISH signals (marked by an 
arrowhead) colocalizes with both the Xp Xist and H3K27me3 domains.  Nuclei are stained 
with DAPI.   
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Table 1 The percentage of monoallelic, biallelic, and nonscorable nuclei measured by 
RNA FISH in early and mid-stage ICMs 
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would have to assume that the small population of biallelic nuclei divided at a rate 
approximately three times faster than monoallelic nuclei in the early stage ICM.  Currently, 
there is no evidence of any preferential cell divisions occuring in the ICM.  Ruling out Xp 
transcription as a consequence of escape, Xp genic reactivation occurs earlier than previously 
determined by analysis of inactive-X epigenetic markers.  Remarkably, genic reactivation is 
also evident in the presence of Xp-Xist coating and H3K27me3 accumulation on the Xp.
There is some evidence that repressed genes can be poised for expression, producing 
truncated transcripts prior to transcriptional activation.  To confirm our RNA FISH results, I 
isolated poly-adenylated mRNA transcripts from individual ICMs obtained from crosses 
between M. domesticus (CD1) and M. molossinus (JF1) strains.  Utilizing single nucleotide 
polymorphisms (SNPs) between the two mouse strains, I determined the allelic distribution 
of X-linked gene transcripts by quantitative RT-PCR.  I first measured expression of Xist 
RNA.  In early F1 ICMs, Xist transcription was detectable exclusively from the Xp (Figure 
7A).  At mid-stage, Xist transcription was maintained on the Xp (Figure 7A) consistent with 
Xp-Xist coating, which was evident by RNA FISH (Figure 6E).  I next quantified the 
expression of maternal and paternal alleles for four X-linked genes (Ube1x, Rnf12, Ddx3x, 
Pdha1), which were previously determined to exhibited imprinted Xp silencing in 
extraembryonic tissues (Kalantry et al., 2009).  All four X-linked genes exhibited biased Xm 
expression in early ICMs (Figure 7A).  For Ube1x and Rnf12 very little Xp expression could 
be detected in early ICMs.  Paternal silencing of Pdha1 and Ddx3x was less complete but still 
favored expression from the Xm.  These data agree with our RNA FISH results and verify 
that imprinted XCI is present in early stage ICMs.  In contrast, when individual mid-stage  
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Figure 7 X-linked gene expression assayed by allele-specific RT-PCR.   
Mating JF1 females to CD1 males generated F1 hybrid embryos.  Xm and Xp transcripts 
were distinguished utilizing single nucleotide polymorphisms between the two strains.  
(A) Allele-specific expression was analyzed for Xist, Ube1x, Rnf12, Pdha1, and Ddx3x.  
Lane 1, Xm allele; Lane 2, Xp allele; Lane 3 equal amounts of Xm and Xp allele; Lanes 
4-6 representative early F1 hybrid ICM samples; Lane 7-9 representative mid-stage F1 
hybrid ICM samples. Analysis of Xist expression illustrates that in both early and mid-
stage ICMs, Xist is expressed from the Xp.  In early ICMs, X-linked gene expression for 
Ube1x, Rnf12, Pdha1, and Ddx3x is largely from the Xm allele.  In mid-stage ICMs there 
is increasing Xp expression of Xp-linked genes. (B) Average Xm and Xp contributions 
were calculated as a percentage of total expression (Xm+Xp).  There is a statistically 
significant increase in average Xp expression in mid-stage ICMs for each X-linked gene 
analyzed (p<0.01). The number of ICMs examined is presented in the table.    
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Table 2 Mean Percentage of Xp expression as measured by Allele-specific RT-PCR 
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ICMs were analyzed; robust expression from the paternal allele was detected (Figure 7A). 
Ube1x, Rnf12, Pdha1, and Ddx3x all exhibited a statistically significant increase in paternal 
X-linked gene expression in mid-stage as compared to early ICMs (p<0.05; Figure 7B, Table 
2).  These data illustrate the detection of not only nascent transcripts but also spliced 
polyadenylated transcripts confirming an increase in Xp-linked gene expression in mid-stage 
ICMs.  
B) Reactivation of Xp-linked genes occurs exclusively in the epiblast lineage 
We next investigated if biallelic gene expression evident in mid-stage ICMs 
corresponded to the epiblast cell fate.  Lineage commitment in the maturing ICM is 
illustrated by the progressive upregulation and mutually exclusive expression of lineage 
markers Nanog (epiblast) and Gata6 (primitive endoderm), which is resolved from uniform 
expression of these markers in the early ICM (Chazaud et al., 2006).  We analyzed NANOG 
and GATA6 protein in mid-stage blastocysts (Fig. 9A).  At mid-stage NANOG and GATA6 
are not mutually exclusively in the ICM (Plusa et al., 2008).  However, we reasoned that 
changes in protein products might lag behind changes in gene expression; consequently, 
analysis of primary transcripts by RNA FISH might confer a more accurate expression 
pattern of Nanog and Gata6 to be utilized for lineage markers.  We found that Nanog and 
Gata6 nascent transcripts in mid-stage ICMs are largely detected as mutually exclusive cell 
populations (Fig. 9B).  On average approximately 47% of cells per ICM exhibited exclusive 
Nanog expression.  In contrast, approximately 32% of cells exhibited exclusive Gata6 
expression.  On average 21% of cells per ICM co-expressed both lineage markers (Fig. 9B). 
The degree of mutually exclusive lineage marker expression appears to depend upon the 
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maturity of the blastocyst with more developed blastocysts exhibiting fewer cells with 
coexpression.  These data correspond to patterns of Nanog and Gata6 expressions, predicted 
by protein localization at later stages of ICM development, and validate the use of RNA 
FISH to measure Nanog expression in mid-stage ICMs (Plusa et al., 2008).   
Restriction of Nanog expression to epiblast progenitors appeared more complete in 
further developed mid-stage blastocysts.  Therefore, in the following experiments, I limited 
our assays to isolated ICMs from blastocysts of approximately 58-64 cells.  In these ICMs, I 
assayed Nanog expression in cells that exhibited biallelic expression of X-linked genes Atp7a 
and Mecp2.  I found that most cells expressing Atp7a and Mecp2 from both X-chromosomes 
also expressed Nanog (Figure 8D). The reverse was true for Gata6 expression, which when 
assayed in independent experiments, was rarely detected in cells exhibiting biallelic X-linked 
gene expression (Fig. 9D).  Utilizing Nanog as an epiblast specific marker, I located the cells 
exhibiting biallelic X-linked gene expression to the epiblast progenitor population.  Biallelic 
gene expression is therefore biased to the epiblast cell fate and not simply a function of 
incomplete Xp silencing during preimplantation development.  I conclude that Xp expression 
in mid-stage ICMs is a result of reversing imprinted XCI.  
C) Chromosome-wide transcription occurs in the presence of Xist Coating 
Together, our RNA FISH and allele-specific RT-PCR results show reactivation of 
seven Xp-linked genes occurs in the presence of Xp-Xist coating.  In order to determine the 
broader transcriptional status of the Xp, I next hybridized with a Cot-1 DNA probe and Xist 
probe in our RNA FISH experiments.  Under RNA FISH conditions, Cot-1 DNA hybridizes 
to transcribed repetitive sequences of the genome, both inter- and intragenic (Hall et al., 
2002).  In combination with a Xist probe, Cot-1 RNA FISH has been previously utilized for  
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Figure 8 Nanog transcripts are associated with biallelic X-linked gene expression.   
(A) Colocalization of NANOG and GATA6 (merge) can be detected in some ICM 
cells at mid-stage. (B) The distribution of Nanog (black) and Gata6 (grey) transcripts 
measured by RNA FISH is graphed as % of total cells per ICM.  The majority of cells 
exhibit mutually exclusive transcription of Nanog (black) and Gata6 (grey). (C) The 
% nuclei per mid-stage ICM (y-axis) that scored positive or negative for Nanog (top 
box plots) and Gata6 (bottom box plots) transcripts (x-axis) are graphed in side-by-
side boxplots for X-linked genes Atp7a (left) and Mecp2 (right).  Nonoverlapping 
boxplots imply that biallelic cells are skewed toward Nanog expression; monoallelic 
cells are skewed toward Gata6 expression.  
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Figure 9 Mid-stage ICMs exhibit transcription within the Xp-Xist domain.   
Cot-1 DNA (red) and Xist (green) probes were used in RNA FISH experiments to 
determine general Xp transcriptional status. (A) In the trophectoderm, the Cot-1 probe 
does not hybridize to the Xist coated region of the Xp, forming what is referred to as 
the Cot-1 hole.  Line scans indicate the relative intensities of DAPI, Cot-1, and Xist 
signals. (B) Representative mid-stage ICM nuclei indicate mutually excluded or 
overlapping patterns. (C) The average distribution of nuclei with mutually excluded or 
overlapping Cot-1 and Xist RNA FISH signals are graphed as a percentage of total 
nuclei per mid-stage trophectoderm (TE), early ICM, and mid-stage ICM.  The bracket 
represents a statistically significant increase in the percentage of cells exhibiting 
overlapping FISH signals in mid-ICMs compared to early ICMs.  
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Figure 10 Epigenetic marks associated with transcription overlap the Xp EED 
domain.   
(A) A confocal section of a mid-stage blastocyst immunostained for EED (red, first panel) 
and H3K4me2 (green, second panel).  EED marks the Xp as an enrichment domain.  In 
the cropped image, an ICM nucleus (arrowhead) exhibits H3K4me2 staining, a mark of 
transcription, within the Xp EED domain (merge, third panel).  (B) In order to determine 
the relative number of ICM nuclei, as compared to CDX2 positive trophectoderm nuclei, 
that exhibited Xp H3K4me2 staining, blastocysts were immunostained for EED (green, 
second panel), H3K4me2 (red, third panel), and CDX2 (cyan, fourth panel).  In the 
cropped image, a CDX2 negative nucleus (arrowhead) exhibits H3K4me2 signal 
overlapping the Xp EED domain (merge, fifth panel).  DAPI stains all nuclei.  (C) The 
graph represents the distribution of Xp EED domains that exhibit H3K4me2 signal.  
Distributions are graphed as a percentage of total trophectoderm or total ICM nuclei per 
embryo.  A red line represents the average.  N = the number of embryos analyzed.   
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visualization of general transcription within the Xist RNA domain.  It has previously been 
shown that the X-chromosome is devoid of Cot-1 hybridization when gene silencing is 
established (Chaumeil et al., 2006; Namekawa et al.). Consistent with predominant Xp-
silencing, I detected mutually exclusive Xist and Cot-1 RNA FISH signals in the majority 
(~82%) of trophectoderm nuclei of mid-stage blastocysts (Figure 9a).  In contrast, when I 
performed RNA FISH on mid-stage ICMs, I detected nuclei with overlap of Cot-1 and Xist 
RNA FISH signals (Figure 9b). Cot-1 RNA FISH signal typically overlapped the exterior of 
the intense Xist domain although nuclei were also detected that exhibited an Xp-Xist domain 
completely overlapped by Cot-1 RNA FISH signal.  I quantified the number of nuclei per 
mid-stage ICM that exhibited patterns of mutually exclusive or overlapping RNA FISH 
signals.  On average, 45% of nuclei per mid-stage ICM exhibited overlapping signals of Cot-
1 and Xist.  The ICM as compared to the trophectoderm is therefore enriched for nuclei 
exhibiting Cot-1 signal overlapping the Xp-Xist domain.  This pattern of overlap is not 
simply characteristic of ICM cells, in general, as I detected a significant (p<0.01) increase in 
the number of nuclei with overlap when I compared early to mid-ICMs (Figure 9c).  This 
increase in the number of nuclei exhibiting transcription from within the Xist RNA domain is 
consistent with general Xp reactivation occurring in the presence of Xist coating.  To our 
knowledge, this is also the first observation that transcription can occur within an Xist 
domain, as previously Xist coating was thought to cause formation of the Xi silent domain, 
which has typically been defined by the absence of Cot-1 RNA FISH signal (Chaumeil et al., 
2006). 
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D) H3K4me2 overlaps the Xp EED domain 
Once XCI is established, the chromatin of an inactive X-chromosome is characterized 
by depletion of histone modifications associated with gene expression.  This depletion can be 
detected at the cytological level by exclusion of di-methylation of histone H3 at lysine 4 
(H3K4me2) from the Xp EED domain.  I performed immunostaining on mid-stage blastocyst 
to detect H3K4me2 and EED (Figure 10A and B).  ICM nuclei were distinguished by the 
absence of CDX2, a marker of trophectoderm (Figure 10B).  In the preimplantation stage 
embryo, some nuclei in the mid-stage blastocyst exhibited H3K4me2 signal that overlapped 
the Xp EED domain, suggestive of general Xp transcription.   I observed an average 12% of 
trophectoderm nuclei with this staining pattern.   In contrast, an average 43% of CDX2 
negative ICM nuclei exhibit H3K4me2 staining that overlaps the Xp EED domain (Figure 
10C).  The relative preference for this staining pattern in the ICM, relative to trophectoderm 
nuclei of the same embryo, is consistent with Xp reactivation.  It is also interesting that the 
Xp in both ICM and trophectoderm nuclei exhibited general Xp transcription in the presence 
of both Xist coating (Figure 9C) and PRC2 (Figure 10A and B); these surrogate markers of 
XCI are likely unable to prevent transcription, irrespective of lineage.   
E) Conclusions 
Here, I present evidence that reversal of imprinted XCI initiates earlier than 
previously determined by analysis of Xi epigenetic markers.  Reactivation of the Xp, as 
evident by an increase in Xp-linked gene activity, initiates in the mid-stage ICM coincident 
with, rather than as a consequence of, epiblast lineage specification.    Chromosome-wide 
transcription is evident in the presence of Xist coating, as well as the cytologically detectable 
PRC2 and H3K27me3 domains.  Together, these observations suggest that, particularly at 
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this early stage of embryonic development, these epigenetic marks classically analyzed at the 
cytological level to generalize X-chromosome activity do not accurately reflect the 
expression state of individual X-linked genes. The concept that reactivation of X-linked 
genes could occur in the presence of the chromatin modification H3K27me3, which is known 
to stabilize XCI, is especially surprising.  I suggest two possible explanations for our 
observations.   
First, it is currently speculated that Xist RNA recruits PRC2 to the X-chromosome 
(Zhao et al., 2010).  The mechanism of how this recruitment occurs, and how H3K27me3 is 
spread to decorate the entirety of X-chromosome chromatin, is poorly understood.   It is 
possible that Xist does not coat the entire X-chromosome in a linear fashion.  Xist transcripts 
may favor certain DNA sequences defined as booster elements (Gartler and Riggs, 1983).  
Xist transcripts can associate with autosomal DNA sequences, suggesting that Xist coating is 
not dependent on unique X-linked gene sequences.  This led to the hypothesis that repetitive 
sequences may function as booster elements (Lyon, 1998).  A possible explanation for ICM 
reactivation in the presence of Xist coating is that, even though Xist and PRC2/H3K27me3 
are detected cytologically to accumulate on the Xp, the spread of these epigenetic 
modifications may be incomplete.  In both early and mid-stage ICMs, Xist coating and 
PRC2/H3K27me3 may not have reached all genic loci.  In the absence of epigenetic 
modifications at individual loci, there exists no block to prevent gene specific reactivation 
occurring prior to the chromosome-wide removal of epigenetic modifications.  Due to the 
small number of cells and heterogeneity in the developing ICM, I are limited to cytological 
detection of these epigenetic modifications, which is at low resolution as compared to the 
level of DNA sequence.  In the future with improvements in technology, high-resolution 
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analysis of H3K27me3 by chromatin immunoprecipitation will determine how this 
modification spreads to genic loci during preimplantation development.   
The above explanation suggests that genic reactivation in the ICM can be explained 
by piecemeal spreading of Xi epigenetic modifications across the Xp.  Recent data have 
shown that Xist transcripts first concentrate near the Xist locus and then coating spreads to 
the rest of the chromosome (Sarma et al., 2010).  This is consistent with the long held 
opinion that gene silencing occurs first at X-linked genes located nearest the Xist locus, 
extends linearly to distant regions of the X-chromosome (Huynh and Lee, 2003).  Although 
our study analyzes a subset of X-linked genes, the proximity to Xist had no consequence in 
the propensity to reactivate.  The seven X-linked genes analyzed were chosen at random and 
are located along the length of the X-chromosome; yet all genes exhibited reactivation in the 
presence of Xist/PRC2 accumulation.  The absence of repetitive element silencing and the 
presence of H3K4me2 immunostaining on the Xp also indicated chromosome-wide 
reactivation.  I argue it is unlikely the reactivation I have observed is due to a propensity of a 
subset of X-linked genes to reactivate. 
I therefore favor a second possible explanation for reactivation in the presence of 
PRC2/H3K27me3 enrichment.  While H3K27me3 is a chromatin modification generally 
associated with gene repression, the exact mechanism for how H3K27me3 inhibits 
transcription is unknown.  I have shown microscopically that the Xp in ICMs is enriched for 
both H3K4me2 and H3K27me3.  In ES cells, ‘bivalent’ genes have been defined by the 
presence of both active and repressive histone modifications, particularly the presence of 
H3K4me3 and H3K27me3.  It was originally reported that these bivalent genes were 
transcriptionally inert (Boyer et al., 2006; Lee et al., 2006).  However, utilizing more 
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sensitive assays recent results indicate that ‘bivalent genes’ exhibiting H3K4me3 and 
H3K27me3 have engaged RNA Polymerase II at the transcription start site.  In addition, 
while these genes exhibit reduced expression levels compared to the genome average, a 
significant amount of productive RNA Polymerase II elongation was detected (Min et al., 
2011).  These data indicate that in the presence of epigenetic marks associated with 
activation, H3K27me3 may not be sufficient to block productive transcription.  A minority of 
X-linked genes has been shown to escape XCI in somatic tissues, usually in a tissue-specific 
manner (Reinius et al., 2010).  Interestingly, CHIP-sequencing and RNA-sequencing in TS 
cells have been performed by a postdoctoral fellow in our lab, Mauro Calabrese; in Calabrese 
et al., he shows that a subset of escaping genes are bound by PRC2 and exhibit H3K27me3, 
again indicating that this histone modification associated with XCI is not sufficient to prevent 
X-linked gene expression. 
F) Materials and Methods 
Embryo collection and Immunosurgery 
 Embryos were collected from natural mating of either Mus. domesticus CD1 females 
(RNA FISH) or Mus. molossinus JF1 females (RT-PCR) to CD1 males carrying the X-GFP 
(D4.EGFP) transgene (Hadjantonakis et al., 1998).  Female blastocysts were distinguished 
from males by GFP expression.  Mice were exposed to light daily between 6:00AM and 
6:00PM.  The morning of the day the plug was detected was considered E0.5.  Early 
blastocysts were collected between E2.75 and E3.0 (approximately 66-72 hours post-
copulation).  Mid-stage blastocysts were collected between E3.5 and E3.75 (approximately 
84-90 hours post-copulation).  Mid-stage blastocysts were distinguished from early-stage 
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blastocysts because the blastoceol cavity was expanded by the mid-stage.  Immunosurgery 
procedures were performed as previously described in Chapter 2.  
Immunostaining 
 Protocols for immunostaining were described in Chapter 2.  Primary antibodies were 
Nanog (Chemicon, 1:1000), Cdx2 (Biogenex, 1:200), Gata6 (R&D Systems 1:1000), 
H3K27me3 (Upstate, 1:250), H3K4me2 (Upstate, 1:100), and EED (Arie Otte, Slater 
Institute, Amsterdam, The Netherlands, 1:200).   
RNA FISH 
 RNA FISH probes were previously listed in Chapter 2, except for the Gata6 probe 
that was RP24_329F11.  To detect repetitive sequence expression, Mouse Cot-1 DNA 
(Invitrogen) was used as a RNA FISH probe.  The labeling and precipitation protocol was 
described in Chapter 2 with one modification that Cot-1 DNA is not added as a blocking 
agent in the precipitation protocol.  Gata6 FISH probes were tested in ES and 
extraembryonic endoderm (XEN) cell lines, respectively.   
 For combined immunostaining of H3K27me3 and RNA FISH, ICMs were 
permeabilized in CSK for 15 seconds, CSK plus 0.05% tritonX-100 for 30 seconds, CSK for 
15 seconds, and then plated onto 1x Denhardt’s coated coverslips in CSK plus 1% 
paraformaldehye.  After air-drying the ICMs on the coverslips, ICMs were fixed in 3% 
paraformaldehye for 10 minutes at room temperature.  ICMs were immediately prepared for 
immunostaining.  Immunostaining was performed as described in Chapter 2 with the 
exceptions that the 0.05% tritonX-100 steps is removed and all steps are performed under 
RNAse free conditions by adding RNAsin to the 1x PBS 6mg/ml BSA and the 10% goat 
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serum.  After immunostaining, ICMs were fixed in 2% paraformaldehye for 5 minutes at 
room temperature and then immediately prepared as described in Chapter 2 for RNA FISH. 
Statistical Analysis of RNA FISH 
 RNA FISH nuclei were classified as biallelic, monoallelic, or 
nonscorable/undetermined.  Nuclei were classified as nonscorable/undetermined when no 
RNA FISH signal could be detected.  For each X-linked gene, the total number of the three 
classes of nuclei was compared between early and mid-stage ICMs.  Binomial exact test was 
used to verify that nonscorable data between stages were equivalent.  Fisher’s Exact test was 
used to compare the three categories between early and mid-stage ICMs.  P values of p<0.01 
was considered significant.  The procedure was repeated for the Cot-1 and Xist RNA FISH 
experiments except the nuclei were scored as either excluded, overlapping, or 
nonscorable/undetermined.  
Microscopy 
 Images for RNA FISH were obtained using a Leica DML fluorescence microscope 
with a Q-imaging Retiga 200R camera and Q-capture software. Images were processed using 
SPOT RT Software (Diagnostic Instruments).  For Cot-1/Xist RNA FISH and 
H3K4me2/H3K27me3 immunostaining experiments, images were obtained on a Zeiss710 
confocal microscope.  Individual confocal sections were analyzed using Zen software to 
determine overlap between signals.  To determine relative intensity values obtained in the 
Cot-1 RNA FISH experiments, we generated line traces across nuclei using NIH Image J 
software and used the plot profile tool to measure the intensity across the line traces.  
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RT-PCR 
Polyadenylated mRNA was prepped using the Dynabeads mRNA DIRECT Micro Kit 
(Invitrogen, 610.21).  Individual ICMs were lysed in 100 ul of lysis/binding buffer following 
manufacturers protocol.  For RT-PCR, SuperScript III One-Step RT-PCR Platinum Taq 
(Invitrogen, 12574-035) was used to amplify the cDNA.  A portion of the final RT-PCR 
product was used to perform one round of amplification in the presence of a trace amount of 
32P-dCTP (Perkin Elmer, BLU513H) to minimize heteroduplexes and to radioactively-label 
the RT-PCR product. The final PCR product was digested with the appropriate restriction 
enzyme, run on a 10% acrylamide gel, and exposed to film.  All RT-PCR primers were 
previously described (Kalantry et al., 2009).  Band intensities were quantified using Adobe 
Photoshop CS3 Extended software.  Percent paternal expression was calculated as a 
percentage of total intensity of combined maternal and paternal-specific bands (%Xp= 
Xp/[Xm+Xp]).  In case of multiple maternal- or paternal-specific bands, the band intensities 
were added to yield a single value.  The average %Xp expression was compared between 
early and mid-stage ICMs for each X-linked gene.  P-values were calculated using two-tailed 
t-tests where the null hypothesis is that the mean %Xp of early and mid-stage samples are the 
same.   
 
 
 Chapter 4:  Extinction of Xist coating has no effect on Xp genic reactivation
The data presented in Chapter 3 argue against loss of the Xist coat as a prerequisite to 
initiate Xp reactivation.  One possibility that may explain reactivation of the Xp in the 
presence of Xist coating, without invoking Xist-independent mechanisms for reactivation, is 
that reduced transcription of the paternal Xist allele may occur simultaneously with 
chromosome-wide reactivation.  If so, then nuclei exhibiting biallelic X-linked gene 
expression represent nuclei with lower levels of Xist coating.  Thus, decreasing amounts of 
Xist coating could trigger Xp reactivation, supporting the previous models for 
reprogramming XCI.   
In the ICM, I saw no indication that the amount of Xist coating, measured by RNA 
FISH, was associated with an active Xp; I also detected no obvious differences between the 
Xp-Xist domains in ICM nuclei as compared to trophectoderm nuclei.  However, subtle 
decreases in amount of Xist transcripts coating the Xp may be undetectable by RNA FISH.  I 
considered performing quantitative RT-PCR in the context of single cells to measure 
transcription of Xp-Xist, but I ruled out this experiment, as the total abundance of Xist 
transcripts is not a direct measure of the amount of transcripts coating the Xp.    It is unclear 
how Xist RNA coats the X-chromosome, but data support the conclusion that Xist coating 
depends, in part on stabilization of Xist transcripts in the nucleus (Royce-Tolland et al., 
2010).  I took an unconventional approach to address the possibility that decreasing amounts 
of Xist coating triggers reactivation.  I sought to conditionally deplete Xist coating in mid-
 55 
stage ICMs.  I reasoned that if Xp gene expression were regulated independently of Xist 
RNA then precocious loss of the Xp-Xist coating would have no effect on the kinetics of 
genic reactivation.  In contrast, if decreasing levels of Xist trigger reactivation, then dramatic 
loss of Xist should trigger Xp reactivation.   
A) Increased NANOG dosage results in loss of Xi epigenetic markers of XCI 
For these experiments, I took advantage of a genetic mutation in Grb2, a key adaptor 
molecule necessary for MAP kinase signal transduction. Activation of MAPK signaling in 
both ICMs and ES cells has been shown to negatively regulate Nanog expression.  
Conversely, blocking MAPK signaling in ICMs is believed to release Nanog repression, 
resulting in transformation of primitive endoderm cells to epiblast.  Consistent with this 
hypothesis, Grb2 -/- embryos exhibit early post-implantation lethality due to a lack of 
endodermal differentiation (Hamazaki et al., 2006; Pawson and Scott, 1997).   
NANOG is highly variable in the mid-stage ICM with strong immunostaining 
detectable in only a subset of ICM cells.  In contrast, Grb2 -/- blastocysts exhibit strong 
NANOG immunostaining in the majority of ICM cells (Figure 11A) (Chazaud et al., 2006). 
Grb2 -/- blastocysts were phenotypically indistinguishable from littermate controls, and no 
cell death has been reported in Grb2 -/- ICMs as compared to littermate controls.  It has been 
reported that NANOG directly represses Xist expression in undifferentiated mouse ES cells 
(Navarro et al., 2008).  In support of these results, I observed that female mid-stage E3.5 
Grb2 -/- blastocysts exhibit uniform loss of EED and H3K27me3 Xp enrichment throughout 
the ICM (Figure 11A, B, and C).  I also found a significant reduction in the number of ICM 
cells with Xp-Xist coating in Grb2 -/- ICMs compared to littermate controls (Figure 12A).  I 
noted that even when Xp-Xist coating was detectable in Grb2 -/- mid-stage ICMs, the density 
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of the coat was significantly reduced.  The depletion of Xist coating at mid-stage was in 
contrast to Grb2 -/- embryos isolated between the 8- to 16-cell stage, which exhibited normal 
Xp-Xist coating (data not shown).  Xist coating the Xp in Grb2 -/- cleavage stage embryos 
indicates that imprinted XCI initiated normally as would be predicted from the low levels of 
NANOG reported at the 8-cell stage (Yamanaka et al., 2010).   Trophectoderm cells appeared 
to maintain Xi epigenetic markers in wild type and Grb2 -/- blastocysts (Figure 11A and B).   
B) Ectopic loss of Xist coating has no effect on Xp reactivation kinetics 
Interestingly, the loss of Xp Xist coating in the Grb2 -/- ICMs did not result in 
reactivation of Xp genes.  For the four genes I analyzed (Ube1x, Rnf12, Atp7a, and Abcb7) 
monoallelic X-linked gene expression was detectable in cells without visible Xp-Xist coating 
(Figure 12B and C).  I found similar patterns of monoallelic and biallelic Xp-linked gene 
expression in female Grb2 -/- ICMs as compared to female littermate controls, irrespective of 
the amount of Xist coating the Xp (Figure 12B).  Despite widespread loss of Xp-Xist and Xp-
EED accumulation, reactivation in Grb2 -/- ICMs occurs normally.  Analysis of ICM nuclei 
from late stage blastocysts (~128 cells) also indicates that in the absence of Xist coating, Xp 
silencing can be maintained through cell divisions (Figure 13A and B). These data rule out 
the possibility that the reactivation detected in the mid-stage ICM is due to subtle decreases 
in the levels of Xist and show that genic silencing in the ICM can be maintained independent 
of cytologically detectable Xist coating and PRC2. 
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Figure 11 Grb2 -/- ICM cells exhibit loss of Xist transcripts and EED on the Xp.               
(A) Mid-stage blastocysts immunostained for NANOG (red, first panels) and EED 
(green, second panels).  In wild type blastocysts (top panels), EED accumulates on the 
Xp in NANOG positive nuclei as seen by the yellow foci (merge, third panels).  
However, in all but one NANOG positive nuclei of Grb2 -/- blastocysts (right panels), 
Xp EED foci are undetectable (merge, third panels).  DAPI stains all nuclei.             
(B) Optical sections of mid-stage blastocysts immunostained for CDX2 (red, first 
panels) and H3K27me3 (white, second panels). DAPI stains all nuclei. The cropped 
images in the left corners represent ICM nuclei, which are distinguished by the 
absence of CDX2 staining.  Arrowheads also mark the nuclei in the cropped images.  
In WT ICM nuclei (top row), H3K27me3 accumulated on the Xp.   The Grb2 -/- ICM 
(bottom row) is characterized by the absence of H3K27me3 Xp enrichment foci.     
(C) The graph illustrates the number of H3K27me3 Xp foci detected in ICM nuclei of 
WT and Grb2 -/- blastocysts. 
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Figure 12 Loss of Xist coating does not alter reactivation kinetics.   
(A) Wild type (top panels) and Grb2 -/- (bottom panels) mid-stage ICMs assayed by 
RNA FISH for transcripts of Xist/Tsix (green).  The graph indicates the average % of 
cells per ICM that exhibit Xist coating in Grb2 -/- as compared to wild type littermate 
controls.  (B) Nuclei from wild type (upper rows) and Grb2 -/- (bottom rows) ICMs 
assayed for transcripts of X-linked genes Rnf12, Atp7a, and Abcb7 (red signals marked 
by arrowheads, left panels) and Xist/Tsix (green, middle panels).  Grb2 -/- ICM nuclei 
(bottom rows) show monoallelic expression in the absence of the Xp-Xist domain 
(merge, right panels).   The graph at the right indicates the distribution of biallelic X-
linked gene expression in Grb2 -/- ICMs as compared to wild type.  The data are 
presented as a % of total cells/ICM. 
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Figure 13 Grb2-/- ICM nuclei maintain Xp-linked gene silencing through cell divisions.  
(A) RNA FISH was used to analyze X-linked gene expression (red, arrows) and Xist (green) 
in Control and Grb2-/- late stage ICMs.  Representative images of Abcb7 expression (top 
panel) and Ube1x expression (bottom panel) are provided.  (B) The distribution of nuclei in 
Control and Grb2-/- ICMs exhibiting Xist coating is indicated in the graph.  (C) The 
distribution of monoallelic and biallelic Abcb7 nuclei is graphed for control and Grb2-/- late 
stage ICMs.  N=number of ICMs analyzed.   
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C) Maintenance of Imprinted XCI in the blastocysts 
Modifications and proteins in addition to PRC2-mediated H3K27me3 have been 
defined in extraembryonic tissues to maintain XCI (Chong et al., 2007; Garrick et al., 2006; 
Kohlmaier et al., 2004; Plath et al., 2004).  I tested if any of these Xi epigenetic markers are 
also present on the Xp at the blastocyst stage.  Immunostaining for RING1b, H4K20me1, 
ATRX, and SMCHD1 was first performed on female trophectoderm stem cells (TS cells) 
(data not shown).  TS cells are derived from the trophectoderm of E3.5 blastocysts.  Despite 
localization of ATRX and SMCHD1 in TS cells, only RING1b and H4K20me1 accumulated 
on the Xp in mid-stage blastocysts (Figure 14A and B).  Importantly, while RING1b was 
detected in some NANOG positive ICM nuclei, RING1b was not found to accumulate on the 
Xp in all blastocyst nuclei.  In fact, a minimal number of nuclei per blastocyst showed 
RING1b Xp foci (Figure 14B), which is consistent with a previous report (de Napoles et al., 
2004).  H4K20me1 was weakly detected to accumulate on the Xp at the mid-stage blastocyst, 
and a significant number of nuclei showed no H4K20me1 foci (Figure 14C).  Given these 
results in WT blastocysts, it is unlikely that the presence of these modifications is responsible 
for maintenance of Xp silencing, in the absence of Xist coating and H3K27me3, which is 
found in Grb2 -/- ICMs.  Additionally, in undifferentiated EED-/- TS cells, the Xp exhibits not 
only depletion of H3K27me3 but also depletion of H2A ubiquitination and H4K20 mono-
methylation; however, EED-/- TS cells do not exhibit reactivation of the imprinted Xp 
indicating that these marks are not necessary for silencing (Kalantry et al., 2006). 
D) Conclusions 
In chapter 4, I have shown that in mid-stage ICMs Xp-genic silencing, at least for a 
subset of X-linked genes, can be maintained even after inactive-X epigenetic marks, Xist 
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Figure 14 Characterization of XCI-associated epigenetic marks in mid-stage 
blastocysts.   
(A) Immunostaining for RING1b (red, second panel) and NANOG (green, third panel).  
RING1b is found to accumulate on the Xp (arrow) in a NANOG positive ICM nucleus.  
(C) Despite localization of RING1b to the Xp in some mid-stage blastocyst nuclei, on 
average 25% of total cells in the embryo exhibited Xp RING1b foci.  (D) H4K20me1 
(red, second panel) and EED (green, third panel) immunostaining in mid-stage blastocyst.  
EED foci (green, third panel) mark the Xp in each nucleus.  An arrowhead marks a 
nucleus where the Xp has H4K20me1.  In contrast, an arrow marks a nucleus that does not 
exhibit H4K20me1 staining on the Xp. 
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coating and PRC2/H3K27me3 are removed.  These results in the mid-stage ICM are 
consistent with maintenance of X-linked gene silencing after the loss of Xist expression 
during X-chromosome reactivation in female mouse germ cell development (Sugimoto and 
Abe, 2007).  From these data, I argue that genic reactivation in the ICM is not simply a 
consequence of loss of Xist coating.  Taking into account the findings in both chapter 3 and 
chapter 4, I propose that reprogramming of imprinted XCI requires two separable events: The 
first step, relief of Xp-linked gene repression, occurs between the early to mid-stage of ICM 
development and results in two active Xs at the mid-stage.  The second step, extinction of 
Xp-Xist coating, occurs in late-stage ICMs by reprogramming of the Xp-Xist locus to 
suppress Xp-Xist expression.  Together, genic reactivation and Xist reprogramming reset both 
X-chromosomes for initiation of random XCI in the epiblast.  The results presented here are 
the first to report maintenance of imprinted gene silencing in the absence of Xp-Xist coating.  
These data suggest that Xp-linked gene silencing involves unknown mechanisms, which are 
independent of the presence of the Xist coat.   
It is hypothesized that transcription factors that mediate pluripotency, particularly 
Nanog, directly couple X-chromosome reactivation to acquisition of ground-state 
pluripotency.  In support of this hypothesis, it is reported that NANOG directly binds Xist 
intron 1, represses Xist expression in undifferentiated mouse ES cells, and prevents Xist 
coating (Navarro et al., 2008).  Our study provides in vivo support for and expands on the 
role of NANOG in reprogramming XCI.  Reprogramming in the ICM has been divided into 
Nanog-independent and Nanog-dependent phases (Silva et al., 2009).  I pinpoint genic 
reactivation to the mid-stage ICM, which is prior to upregulation of Nanog expression and 
the defined phase of Nanog-dependent epigenetic remodeling.  Therefore, I conclude that 
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initiation of genic reactivation is coupled to an early step in genome-wide reprogramming, 
which is independent of NANOG.  This conclusion is supported by our observations that 
increased NANOG throughout the ICM did not result in increased Xp-linked gene 
reactivation.   
In Chapter 2 and Chapter 3, I showed that the presence of NANOG, at the levels 
present in the early and mid-stage ICM, did not result in loss of Xp-Xist coating, which 
would appear inconsistent with the Xist gene as a direct target of NANOG repression.  
Female mouse epiblast stem cells (EpiSCs) also maintain Xist coating despite the presence of 
NANOG (Tesar et al., 2007).  Interestingly, EpiSCs express lower levels of Nanog than ES 
cells, and it was shown that overexpression of Nanog in EpiSCs led to loss of inactive-X 
H3K27me3 enrichment (Silva et al., 2009).  I show that ectopic upregulation of NANOG in 
Grb2 -/- mid-stage ICMs forces premature loss of the Xp-Xist domain.  The ability of 
NANOG to suppress Xist expression, therefore, likely depends on the dosage of NANOG.  
Dosage sensitivity in NANOG function may explain why depletion of Xp-Xist coating occurs 
after Xp-linked gene reactivation, in late ICMs and coincident with NANOG upregulation.  
Alternatively, the data presented here cannot rule out the possibility that Xp-Xist repression 
requires reprogramming factors in addition to NANOG, which are not present in early ICMs, 
mid-ICMs, or EpiSCs.   
E) Materials and Methods 
Embryo collection and Immunosurgery 
 Embryos were collected and immunosurgery were performed as previously described.  
Mice carrying a null mutation in Grb2-/- (GrmtmPaw2) were obtained from Tony Pawson 
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(University of Toronto, Canada) (Cheng et al., 1998).  Grb2+/-  females were crossed CD1 
males carrying the X-GFP (D4.EGFP) transgene (Hadjantonakis et al., 1998).  From these 
crosses, Grb2+/-; X-GFP males were generated.  Timed matings were performed with Grb2+/-; 
X-GFP males and Grb2+/-  females.  Preimplantation embryos were collected according to the 
procedures described in previous chapters and females were distinguished from males based 
on the presence of GFP.  Grb2+/-  blastocysts and ICMs were distinguished from littermate 
controls (Grb2+/+ and Grb2+/- ) based on the upregulation of Nanog expression and down 
regulation of Gata6 expression in the ICM.  Nanog expression is unchanged in Grb2-/- 8-cell 
stage embryos, but I expect 12.5% of the embryos generated from this cross to be Grb2-/- and 
female.  Therefore, when performing analysis 8-cell stage embryos four different litters were 
analyzed; mean number of embryos generated was 9 with approximately 50% of the embryos 
scoring GFP positive.   
Immunostaining 
 Protocols for immunostaining were described in Chapter 2.  Primary antibodies were 
Nanog (Chemicon, 1:1000), Cdx2 (Biogenex, 1:200), Gata6 (R&D Systems 1:1000), 
H3K27me3 (Upstate, 1:250), H4K20me1 (Upstate, 1:100), Ring1b (Arie Otte, Slater 
Institute, Amsterdam, The Netherlands, 1:50), SmcHD1 (1:200), Atrx (1:100), and EED 
(Arie Otte, Slater Institute, Amsterdam, The Netherlands, 1:100) 
 
 
Chapter 5:  Discussion 
A) Preliminary results, Xist coating in Initiation of Random XCI 
XCI is the conserved method of female dosage compensation from marsupials to 
eutherians.  Interestingly, marsupial imprinted XCI occurs in the absence of the Xist gene, as 
the non-coding RNA is thought to have evolved de novo in eutherians from the 
pseudogenization of a protein-coding gene Lnx3 (Duret et al., 2006).  Unlike Xist, Lnx3 
expression is not sex-specific and has no defined role in marsupial imprinted XCI.  Other 
features of XCI are shared, such as the enrichment of H3K27me3 at the Xi domain, although 
the abundance of H3K27me3 and, in turn, Xp silencing is less stable in marsupials (Chaumeil 
et al., 2011; Mahadevaiah et al., 2009).   
 Another example of Xist-independent silencing of X-chromosome sequence is 
meiotic sex chromosome inactivation (MSCI), the silencing of the unpaired X- and Y-
chromosomes during male meiosis (Turner et al., 2002). The possibility exists that initiation 
of imprinted XCI, both in the mouse preimplantation embryo and marsupials, is achieved 
through inheritance of MSCI-mechanisms, such as still unidentified chromatin modifications 
placed on the Xp during spermatogenesis, predisposing the Xp for silencing (Namekawa et 
al., 2010).   Here, I present preliminary data addressing the role of Xist coating in the 
initiation of random XCI.  I argue that if in random XCI, which occurs de novo in the 
epiblast, Xi gene silencing can also be uncoupled from Xist coating; an attractive hypothesis 
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would be that Xist-independent initiation of X-linked gene silencing is generally conserved in 
the XCI process, from marsupial to eutherian.   
Fundamentally, random XCI differs from imprinted XCI in that initiation of random 
XCI requires a choice step.  Choice during imprinted XCI is ‘locked’; the Xp is always the 
inactive chromosome, regardless of X-chromosome ploidy (Thornhill and Burgoyne, 1993).  
Consequently, in extraembryonic tissues, the Xm is active, and embryos that inherit a 
maternal Xist mutation are viable and undergo normal imprinted XCI.  In contrast, the 
number of X-chromosomes that will be inactivated during random XCI is determined relative 
to the ploidy of the cell (Rastan and Robertson, 1985).  Random XCI is initiated when the 
number of X-chromosomes exceeds one in a diploid nucleus. Each cell then makes the 
epigenetic choice to keep one X-chromosome active and to inactivate all supernumerary X-
chromosomes.  
Two different targeted deletions of the Xist gene have led to nonrandom XCI.   
Deletion of the Xist promoter through part of exon 1 results in what the authors concluded as 
secondary nonrandom XCI due to post-choice selection (Penny et al., 1996).  These authors 
suggest that both WT and Xist mutant X-chromosomes can be chosen for silencing, but the 
choice of a mutated X-chromosome is lethal.  These cells fail to inactivate the mutant X-
chromosome and undergo post-choice selection, such that they are depleted during 
development.   These authors concluded that Xist is required for initiation of random XCI; 
however, from their data it is unclear if defective silencing occurred due to defects in 
initiation or maintenance.   
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Another targeted deletion leaves the Xist promoter intact but spans from part of exon 
1 through exon 5.  This deletion also leads to nonrandom XCI, but the authors concluded that 
skewed XCI is due to altered choice, by primary nonrandom XCI (Nesterova et al., 2003; 
Newall et al., 2001).  In this example, the Xist mutant X-chromosome was pre-empted from 
silencing because it was chosen as the active X-chromosome.  Together, these data illustrate 
the difficulty in delineating the role of Xist coating in random XCI from loss of one Xist 
allele.   
Panning and colleges subsequently revisited the mechanism of choice (Royce-Tolland 
et al., 2010).  From their data, they determined that stochastic differences in the production of 
mature Xist transcripts underlie random choice.  Prior to the onset of XCI, Xm and Xp Xist 
alleles both produce limited amounts of Xist transcripts.  The noise inherent to low-levels of 
transcription results in subtle differences in the amount of mature Xist transcripts produced 
from Xm and Xp alleles.  At the onset of XCI, these small differences are amplified and the 
X-chromosome that produced the most mature Xist transcripts is favored as the Xi.  From this 
new model, it can be extrapolated that choice is set when both X-chromosomes are active, 
prior to initiation (Royce-Tolland et al., 2010).  Thus, single Xist mutations cannot be used to 
determine if Xist is required for initiation of Xi gene silencing because the mutant X-
chromosome is never selected for silencing in the first place. 
Understanding whether Xist coating is necessary for silencing in random XCI requires 
generation of homozygous Xist-mutant female embryos, whereby both X-chromosomes have 
an equal chance to be chosen for silencing.  I utilized a 21kb Xist deletion (XistΔ), 
encompassing 5kb upstream of the promoter through exon 3 (Csankovszki et al., 1999).  
Female embryos inheriting a paternal XistΔ deletion (XWT/XistΔ) exhibited 100% lethality 
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(Kalantry et al., 2009).  In brief, XWT/XistΔ females manifest growth retardation at E6.5, and 
uterine re-absorption occurs between E10.5 and E12.5.  Random XCI initiates between E5.75 
and E6.0; I hypothesized I could analyze random XCI in XWT/XistΔ females because the 
initiation phase is prior to manifestation of the phenotype.     
Next I generated homozygous Xist-mutant embryos by crossing heterozygous females 
(XWT/XistΔ) with heterozygous males (XistΔ/Y).  In this cross, 50% of the females are 
expected to be homozygous for the Xist mutant allele (XistΔ/XistΔ).  Because the Xm is 
always active in extraembryonic tissues, XistΔ/XistΔ female embryos were not expected to 
display enhanced defects in the extraembryonic tissue development.  However, XistΔ/XistΔ 
female embryos were not recovered at E6.5, despite evidence of implantation sites in 
decidua.   Consistent with implantation into the uterus, XistΔ/XistΔ females could be 
recovered at E5.5.  Gross analysis of the XistΔ/XistΔ morphology indicated that 
extraembryonic ectoderm was absent; conversely, these embryos contained a hollow space 
(Figure 15A).  Extraembryonic ectoderm contains the trophectoderm stem cell population, 
and the absence of these cells may explain compromised development of XistΔ/XistΔ 
females, which are likely incapable of sustaining development of extraembryonic tissues.  
The surprising enhanced severity of XistΔ/XistΔ compared to XWT/XistΔ is unresolved and 
could be a subject of future research.  
In order to avoid the early implantation lethality found when female embryos 
maternally inherited a Xist mutation, I next utilized a conditional Xist allele (Xist2lox), which 
when recombined by CRE recombinase, removes sequence interior to the loxP sites.  The  
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Figure 15 Epiblast cells exhibit Xi gene silencing in the absence of Xist coating.   
(A) Representative E5.5 XWT/XistΔ (right) and XistΔ/XistΔ (left) female embryos.  The 
extraembryonic ectoderm cells are absent in the XistΔ/XistΔ.   Brackets mark a hollow 
space where these cells should reside.  (B) A RNA FISH probe that detects Xist and Tsix 
RNAs was used to determine the efficiency of CRE-mediated recombination for the 
Xist2lox allele.  The distribution of Xist coating positive and Xist coating negative cells 
are graphed as a percentage of total epiblast cells.  Xist1lox/Xist1lox embryos were 
Sox2cre positive.  (C) Epiblast cells were isolated from Sox2cre positive embryos at 
E6.5.  RNA FISH was performed using probes for Pgk1 (red) and Xist/Tsix (green).  The 
percentage of cells that were scored for each class, Xist coating/monoallelic (left panel), 
no Xist coating/biallelic (middle panel), and no Xist coating/monoallelic (right panel) are 
provided in the bottom corner of each image. 
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loxP sites in the Xist2lox allele are located 5kb upstream of the Xist promoter and within 
exon 3 (Csankovszki et al., 1999).  I mated Xist2lox/Xist2lox females with Xist1lox/Y that 
also carry the Sox2cre transgene (Hayashi et al., 2002).  From these matings, all female 
embryos inherited a mutated Xp-Xist allele; in contrast, only female embryos that inherit the 
Sox2cre will lack Xist expression from both X-chromosomes (Xist1lox/Xist1lox) in the 
epiblast.   Utilizing this mating strategy, I recovered Xist1lox/Xist1lox at E6.5 that 
phenocopied XWT/XistΔ females. 
I used a RNA FISH probe that detects both Xist and Tsix to determine the degree of 
Xist coating found in Xist1lox/Xist1lox (n=4 epiblast) and Xist2lox/Xist1lox epiblast (n=6 
epiblast) at E6.5.  In these experiments, Tsix marks X-chromosomes that have failed to 
generate a Xist coat, locating both X-chromosomes in the nuclei.  I show that approximately 
18% of all epiblast cells in the Sox2cre positive female embryos exhibited Xist coating.  This 
contrast Xist2lox/Xist1lox embryos where Xist coating was detected in 90% of epiblast cells 
(Figure 15B).  The presence of Xist coating in a minority of Xist1lox/Xist1lox epiblast cells 
serves as a positive control for initiation of random XCI, indicating that Xist1lox/Xist1lox 
embryos are not delayed in epiblast development.  By next combining RNA FISH probes for 
the X-linked gene Pgk1 and Xist/Tsix, I analyzed X-linked gene silencing at E6.5.  Of the 
82% of Xist1lox/Xist1lox epiblast cells that did not have Xist coating, 42% of cells were 
biallelic for Pgk1 expression. Remarkably, 40% of epiblast cells exhibited monoallelic Pgk1 
expression (Figure 15C).  The presence of monoallelic nuclei is indicative of X-linked gene 
silencing.  Although suggestive, these data imply that random XCI can occur in the absence 
of Xist coating, but more X-linked genes will need to be analyzed for definitive proof.  
Mouse has been the primary model organism to study eutherian XCI.   Analysis of several 
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placental mammals now indicate diverse patterns of Xist RNA expression and coating during 
the initiation stage of XCI, consistent with our conclusion that initiation of random Xi gene 
silencing is uncoupled from Xist coating (Okamoto et al., 2011).   
B) Future Directions 
1.  Identifying X-linked sequences that regulate initiation of XCI 
Here, I present preliminary observations that extend Xist-independent XCI processes 
to random XCI.  If these observations can be reproduced for multiple X-linked genes, then 
they would challenge that long held hypothesized that XCI in marsupials and eutherians is 
mechanistically different (Chaumeil et al., 2011).  As discussed in the introductory chapters, 
phylogenetic comparisons have shown that differentiation of the X- and Y-chromosomes did 
not occur as a single event.  Genes on the proto-Y degenerated individually, or regionally; 
likewise, compensatory dosage compensation in females probably evolved in a piecemeal 
fashion, with XCI mechanisms gradually encompassing segments of the X-chromosome 
(Jegalian and Page, 1998).   Thus, evolutionary studies are inconsistent with models that 
assume Xi transcriptional repression is a function of whole-chromosome topology.  
Evolutionary models are more consisted with Xi gene expression being determined by local 
or regional elements.   
Mauro Calabrese has performed RNA-sequencing (RNA-Seq) in a panel of TS cells 
derived from crosses of Castaneous (CAST) to C57BL/6J (B6) mice.  Using a strand-specific 
RNA-Seq protocol, single nucleotide polymorphisms (SNPs) between the two strains 
facilitated quantitative comparisons of Xa and Xi transcripts.  From 260 genes for which high 
confidence allelic expression data was obtained, 223 genes were inactivated in TS cells; 
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whereas, 37 genes, depending on the genetic background, exhibited some degree of 
expression from the Xi (Calabrese et al.).  These datasets have provided a useful tool to 
dissect mechanisms regulating X-linked gene expression.  For example, motif analysis has 
identified DNA sequences that are putatively involved in regulating escape from XCI.   
One research group has taken the approach of classifying a limited number of X-
linked genes into early inactivators, late inactivators, and escapers (Patrat et al., 2009).  High-
resolution analysis of X-linked gene expression has not been performed during the initiation 
phase of XCI; RNA-seq performed on pools of preimplantation embryos may be useful in 
expanding on the number of X-linked genes classified as early inactivators, late inactivators, 
and escapers.   Profiling X-chromosome-wide silencing kinetics may identify putative 
sequences that function as local regulators of X-linked gene transcriptional activity.  I 
hypothesize early inactivating genes either contain, or exist near regulatory sequences that 
function as initiation points for silencing.   
Repetitive non-coding sequences, particularly LINE-1 retrotransposons, have 
emerged as attractive facilitators of XCI, perhaps independent of Xist RNA (Chow et al., 
2010; Namekawa et al., 2010).  LINEs are therefore potential candidates for sequence that 
may focally regulate X-linked gene activity, consistent with a recent report in fission yeast 
(Tang et al., 2010; Zaratiegui et al., 2011).  Cot-1 RNA FISH can be used to measure 
expression of repetitive sequences, including LINEs.  I report that mid-stage ICMs are 
enriched, relative to trophectoderm and early ICMs, for nuclei exhibiting Cot-1 hybridization 
internal to the Xist domain, suggesting repetitive sequences exhibit reactivation prior to 
removal of Xist coating.  One testable hypothesis would be that early inactivating genes are 
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in regions of high LINE density, with LINE silencing facilitating initiation, and consequently 
reactivation of X-linked genes during preimplantation development.  
2.  Is there mechanistic link between Xa upregulation and Xi silencing? 
In mammals, research has focused on XCI, which achieves balance in X-linked gene 
expression between the sexes; however, a transcriptional balance is also achieved between X-
chromosomes and autosomes (Cheng and Disteche, 2006; Lin et al., 2007).  General 
transcription levels from active X-linked genes are elevated in both sexes to the relative level 
of genes expression on the pairs of homologous autosomes.  How two-fold upregulation of 
active X-linked genes is achieved remains poorly understood.  One hypothesis is that active-
X upregulation and XCI are mechanistically linked.  In support of this hypothesis, 
H3K27me3 deposition on Xi genes has been shown to be tightly associated with Xa 
transcription (Marks et al., 2009).  Expanding on these observations, Mauro Calabrese 
performed allele-specific, high-resolution H3K27me3 ChIP-sequencing (ChIP-seq) in TS 
cells.  H3K27me3 was observed at Xi genic sequence; both within transcription start sites 
(TSS) and gene bodies, but H3K27me3 was consistently higher at transcription start sites 
(TSSs) of inactivated genes.   Genes that are not transcribed in TS cells did not exhibit 
H3K27me3 enrichment above average Xi levels.  These ChIP-seq datasets indicate that some 
mechanisms of XCI may respond to transcription from the Xa.  Consequently, exploring 
active X-upregulation could facilitate elucidation of XCI, providing a holistic understanding 
of mammalian dosage compensation mechanisms. 
Control of transcription is regulated at multiple levels, including recruitment of RNA 
polymerase II and general transcription factors to the promoter, as well as initiation, 
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elongation, and termination of transcription.  Dosage compensation of active X-
chromosomes exist not only in mammals, but also in Drosophila melanogaster, where the 
single X-chromosome is upregulated two-fold in XY males (Gelbart and Kuroda, 2009).  
Global run-on sequencing (GRO-seq) in drosophila male cell lines has found that 
transcriptional upregulation occurs by enhanced transcriptional elongation at X-linked genes 
(Larschan et al., 2011).  Using these experiments as a guide, allele-specific GRO-seq could 
be performed in mammalian cells, and the RNA Polymerase II pausing and elongation 
indexes for all expressed Xa genes determined.  These Xa indexes then compared to 
autosomal gene average indexes (Core et al., 2008; Larschan et al., 2011).  These methods, as 
described in Larschan et al., may address the unanswered question of if and how transcription 
of X-linked sequence differs from transcription on autosomes.  Likewise, these methods may 
also address the unanswered question of what step in transcription is first blocked during the 
initiation phase of Xi gene repression. 
The Male-specific lethal (MSL) complex regulates dosage compensation in 
Drosophila Melanogaster.  The MSL complex is made up of five proteins, including the 
histone acetyltransferase Males Absent on the First (MOF).  MOF is responsible for 
acetylating histone 4 at lysine 16 (H4K16Ac), a chromatin modification that promotes 
transcriptional elongation by releasing RNA Polymerase II from pausing at promoters 
(Kapoor-Vazirani et al., 2011).  Consistent with a role in regulating transcriptional 
elongation, a 3’ bias of H4K16Ac is a distinctive characteristic of dosage compensated X-
linked genes in Drosophila melanogaster (Gelbart et al., 2009; Kind et al., 2008).  At 
present, it is unknown if chromatin of the Xa in mammals differs in anyway from that of 
autosomes; however, connecting upregulation and XCI mechanisms, H3K27me3 has been 
 75 
proposed to prevent transcriptional elongation.  As a first step in examining Xa chromatin, 
CHIP-seq analysis of H4K16Ac could be used to determine if a similar 3’ bias of H4K16Ac 
is present at transcribed Xa genes in mammalian cells.  In combination with GRO-seq, the 
proposed experiments may lead the way in outlining a putative mechanism for Xa dosage 
compensation.   
C) Concluding Remarks 
The experiments described in these chapters are supported by observations of 
Sundeep Kalantry, a former college, that paternal-Xist mutant (XWT/XistΔ) embryos 
transiently initiate Xp silencing at the 8-cell stage, but at post-implantation the Xp variably 
reactivated in extraembryonic tissues (Kalantry et al., 2009).   These XWT/XistΔ embryos 
phenocopied the developmental defects described in female embryos carrying an EED 
mutation, a complementation that is expected if Xist RNA directly recruits PRC2 (Kalantry et 
al., 2006; Wang et al., 2001; Zhao et al., 2010).  Based on these observations, I confer that 
Xist coating likely behaves as a molecular scaffold, recruiting H3K27me3 and other 
epigenetic modifications to the Xi and initiating folding of the Xi chromosome territory into 
a conformation that is repressive for transcriptional machinery.    
However, the data presented here call into question the requirement for Xist coating 
and H3K27me3 during the earliest phase of XCI; suggestive that large-scale chromatin 
remodeling is not sufficient to determine Xi gene expression patterns.  These observations 
are inconsistent with a role for Xist RNA as the sole initiator of XCI, arguing against the 
repressive compartment model for initiation of genic silencing.   I suggest alternatively that 
XCI in placental mammals has many layers of epigenetic modification, with as-of-yet 
unidentified mechanisms determining Xi gene silencing at the regional, or local level.  This 
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alternative idea is consistent with a chromosome-conformation capture-on-chip (4C) study 
that separates Xist-dependent Xi chromosome conformation from X-linked gene 
transcriptional activity (Splinter et al., 2011).  The locally determined mechanism is likely 
conserved from marsupial to eutherian; conversely, Xist evolved in eutherians to increase the 
efficiency of Xi silencing, supporting site-specific regulatory mechanisms and augmenting 
stable recruitment of chromatin modifications.  Both layers of epigenetic modification are 
probably necessary in differentiated cells for stable maintenance of XCI.  But at the earliest 
phases of the XCI process, such as in the ICM, locally regulated Xi gene silencing is primary 
to Xist dependent heterochromatinization, perhaps because chromosome-wide changes take 
several cell divisions to develop, explaining the Xist-independent reactivation we have 
identified here.   
I began these experiments interested in the association of cell potency and X-
chromosome programming.  I conclude that XCI robustly initiates in the totipotent cells of 
the preimplantation embryo; genic inactivation and reactivation is independent of NANOG.  
These data suggest that there is no clear distinction between X-linked gene activity and the 
pluripotent state.  But rather my data support a direct link between pluripotency-associated 
transcription factors and Xist RNA.  In vivo NANOG levels can regulate Xist expression, 
corroborating previous ex vivo results (Navarro et al., 2008).    These data suggest that X-
chromosome reactivation is not simply a reversal of Xist coating, highlighting how little we 
know about the epigenetic reprogramming of XCI.  I caution that given this complexity, X-
chromosome activation may not be the best indicator of pluripotency, such as it is currently 
utilized in mouse and human ES cell models.   
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  XCI is an established paradigm in the study of epigenetic mechanisms that is often 
examined in ex vivo contexts.  By focusing on in vivo reactivation in the ICM, I gained novel 
insight into mechanisms of XCI.  In combination with other work from this laboratory, our 
perception of the XCI process and the possible role of non-coding RNAs throughout the 
genome have been altered.  We are left with many unanswered questions, setting the stage 
for future exploration into undiscovered factors and highlighting the importance of DNA 
sequence to the mechanisms that determine transcriptional activity of X-linked genes.
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C) Methods 
Mouse Strains 
Mice were maintained on a mixed background.  The Xist2lox conditional allele was 
described (Csankovszki et al., 1999).  The Sox2-cre transgene was previously described 
(Hayashi et al., 2002).  In order to generate XistΔ animals, I mated WT females that carried a 
Zp3-cre transgene with Xist2lox/Y males to generate XWT/Xist2lox; Zp3-cre/+ females 
(Lewandoski et al., 1997).  In the following generation, XWT/Xist2lox; Zp3-cre/+ females 
were mated with Xist2lox/Y males to generate XWT/Xistlox females and Xist1lox/Y males.  
At this point, the Zp3-cre was bred out of the colony. Xist1lox was from then referred to as 
XistΔ because the sequence encompassed by the loxP sites had been permanently 
recombined out.  In order to maintain the colony, XWT/XistΔ were mated to WT males that 
carried the X-GFP allele (Hadjantonakis et al., 1998).  From these crosses, I generated 
XWT/XistΔ-GFP females.   XWT/XistΔ-GFP females were then mated to CD1 males to 
generate XWT/XistΔ females and XistΔ-GFP/Y males.   
Embryo Dissections 
 Whole embryos were dissected in PBS plus 6mg/ml BSA at room temperature (serum 
is to prevent stickiness).  After embryos were dissected out of the deciduas, genotyping was 
performed by lysing entire embryos or micro-dissected embryonic tissue in 50µl of Tail 
Lysis Buffer (50mM Tris pH8.8, 1mM EDTA, and 0.5% Tween) with 200µg/ml of 
Proteinase K.  For RNA FISH on epiblast cells, the epiblast was micro-dissected after whole 
embryo dissection.  To micro-dissect the epiblast, the dissection was performed on glass 
slides.  Glass is used to prevent the embryo from sticking to the surface.  A thinly pulled 
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capillary was used to split the embryo at the embryonic and extraembryonic junction into two 
parts.  The extraembryonic parts were used to genotype the embryos.   
From the embryonic part, I used forceps to carefully remove the embryonic visceral 
endoderm from the epiblast.  Epiblast cells were then incubated in 0.05% trypsin to breakup 
the tissue into small cell clumps.  In more detail, the 0.05% trypsin was pre-warmed to 37°C, 
and epiblast cells were placed in 50µl drops of 0.05% trypsin.  A mouth pipette was used to 
carefully draw the epiblast up and down.  Eventually, the epiblast would breakup into small 
clumps.  The entire process would take less than 1 minute.  Small cell clumps were then 
transferred to M2 plus 10% fetal bovine serum to neutralize the trypsin.  From this point on 
RNA FISH was performed as for the ICMs described in Chapter 1.  The Pgk1 FISH probe 
was previously described in (Kalantry et al., 2006)
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